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ABSTRACT 
The question addressed in this dissertation is whether ultraviolet could be used to inactivate 
airborne PRRS virus.  Specifically, the aim of this research was to determine if ultraviolet 
could be used to prevent the airborne transmission of PRRS virus.  This problem was 
addressed in the logical series of experiments described below. 
 
Chapter 2 addressed the problem of quantifying the concentration of airborne infectious 
PRRS virus at levels sufficient to infect pigs, but below the threshold of microinfectivity 
assays.  This study explored the application of the “continuous-stirred tank reactor (CSTR) 
model” to this problem and validated the CSTR approach using rhodamine B dye as a 
surrogate for aerosolized microbial pathogens in a dynamic aerosol toroid (DAT).    
 
In Chapter 3, the median infectious dose (ID50) of PRRS virus isolate MN-184 via aerosol 
exposure was estimated.  This information was needed to determine the level of ultraviolet 
inactivation necessary to stop transmission of PRRS virus.  Infection occurred at virus 
concentrations too low to quantify by microinfectivity assays.  Therefore, exposure dose was 
determined using two indirect methods ("calculated" and "theoretical").  "Calculated" virus 
dose was derived from the concentration of rhodamine B monitored over the exposure 
sequence.  "Theoretical" virus dose was based on the continuous stirred-tank reactor model.  
The estimation of ID50 was modeled on the proportion of pigs that became infected using the 
probit and logit link functions for both "calculated" and "theoretical" exposure doses. 
 
Chapter 4 established UV254 inactivation constants for:  influenza virus Type A, porcine 
respiratory and reproductive syndrome virus (PRRS virus), bovine virus diarrhea virus 
(BVDV), and reovirus.  Viruses were exposed to various UV254 doses then titrated for 
infectious virus.  Analysis showed that virus inactivation by UV254 was more accurately 
described by a two-stage inactivation model, rather than the traditional one-stage inactivation 
model.  These results provided insight into the dose of ultraviolet required to inactivate 
airborne pathogens (Chapter 5).   
 
vii 
Chapter 5 described the effects of temperature and relative humidity on the inactivation of 
PRRS virus by ultraviolet.  Viral aerosols were exposed to four doses of UV254 under three 
temperature ranges and three relative humidity ranges.  This study allowed for calculating the 
dose of UV254 required to inactivate airborne PRRS virus under various conditions.   
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CHAPTER 1.  REVIEW OF ULTRAVIOLET AND THE MECHANISMS 
UNDERLYING THE INACTIVATION OF INFECTIOUS AGENTS BY 
ULTRAVIOLET IRRADIATION 
 
A manuscript submitted to Animal Health Research Reviews 
 
 
Timothy D. Cutler, Jeffrey J. Zimmerman 
 
ABSTRACT 
We review the principles of ultraviolet (UV) irradiation, the inactivation of infectious agents 
by UV, and current applications for the control of microorganisms.  In particular, 
wavelengths between 200nm and 280nm (germicidal UV) affect the double-bond stability of 
adjacent carbon atoms, including pyrimidines, purines, and flavin.  Thus, the UV inactivation 
of microorganisms results from the formation of dimers in RNA (uracil and cytosine) and 
DNA (thymine and cytosine).  The classic application of UV is the inactivation of 
microorganisms in biological safety cabinets.  In the food-processing industry, germicidal 
UV has shown potential for the surface disinfection of fresh-cut fruit and vegetables.  UV 
treatment of water (potable and wastewater) is increasingly common because the process is 
effective against a wide range of microorganisms, overdose is not possible, chemical residues 
or by-products are avoided, and water quality is unaffected.  UV has been used to reduce the 
concentration of airborne microorganisms in limited studies, but the technology will require 
further development if it is to gain wider application. For bioaerosols, the primary technical 
challenge is delivery of sufficient UV to large volumes of air, but the absence of UV 
inactivation constants for airborne pathogens under a range of environmental conditions 
(temperature, relative humidity) further compound the problem. 
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INTRODUCTION 
The purpose of this review is to provide an overview of ultraviolet and its application for the 
control of microorganisms.  The first work on the inactivation of microorganisms by 
ultraviolet light was published in 1892 (Ward, 1892), with the "germicidal" effects of 
ultraviolet wavelengths reported in 1903 (Barnard and Morgan, 1903).  In 1927, Rivers and 
Gates used ultraviolet to inactivate virus in solution and proved the efficacy of the method 
through subcutaneous inoculation of rabbits.  The use of ultraviolet to inactivate 
microorganisms in the environment began when Wells and Wells (1938) described the use of 
ultraviolet to inactivate microorganisms in hospital operating rooms.  Wheeler et al. (1945) 
used ultraviolet to “disinfect” Army and Navy barracks for the control of airborne rubella 
virus and Streptococcus pyogenes and in 1947, the use of ultraviolet irradiation reportedly 
reduced the spread of airborne "measles" in classrooms (Perkins et al., 1947).  In 1961, Riley 
demonstrated the efficacy of ultraviolet for the control of airborne tuberculosis by showing 
that untreated ventilated air from wards housing infectious TB patients produced infection in 
guinea pigs whereas air irradiated with ultraviolet light did not.  Thereafter, the research 
moved from qualitative to quantitative measures of the effect of ultraviolet on 
microorganisms.  In one of the first papers to quantify the genetic damage induced by 
ultraviolet, Miller and Plagemann (1974) calculated that a dose of 7mJ per cm2 induced the 
formation of 1.7 uracil dimers per mengovirus plaque-forming unit and that dimer formation 
increased the production of empty viral capsids, altered protein structures, and increased 
RNase activity.  Four years later (1978), Sarasin and Hanawalt reported that a 10mJ per cm2 
dose resulted in 7 pyrimidine dimers per simian virus 40 (SV40) genome (Kowalski, 2009).  
With the exception of water treatment applications, relatively little research on the effect of 
ultraviolet on microorganisms was published from the mid-1970s to 2000.  However, 
concerns for bioterrorism, antibiotic-resistant bacteria, and airborne spread of emerging and 
re-emerging pathogens, e.g., pandemic influenza virus and severe acute respiratory syndrome 
(SARS) coronavirus, have stimulated renewed interest in the use of ultraviolet as a microbial 
inactivant (Walker and Ko, 2007).   
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THE ULTRAVIOLET SPECTRUM 
The electromagnetic spectrum includes energies possessing both electrical and magnetic 
properties.  Classified by wavelength and photonic interaction with matter (ionizing or non-
ionizing), these wavelengths vary from very high vibrational energy (1 x 10-7nm) to infinitely 
long wavelengths and encompass all known forms of energy, from high energy gamma rays 
(3 x 10-3nm), microwaves to lower energy radio waves (3 x 1013nm) (Van Heuvelen, 1982).  
Ultraviolet wavelengths lie between the high energy X-rays (≤ 100nm) and the lower energy 
visual spectrum (> 400nm).  Wavelengths longer than 300nm begin the visible spectrum of 
the electromagnetic spectrum, followed by the infrared spectrum beginning at 700nm, 
microwave frequencies (starting at 3 x 106nm), and the radar/radio frequencies (3 x 108nm 
and beyond).  There is no clear delineation between x-rays and the ultraviolet spectrum; 
rather it is the nature of their interaction with matter that best defines the end of x-rays and 
the beginning of the ultraviolet spectrum.  The energy-matter interactions of wavelengths less 
than 100nm result in ionization (a change in atomic charge) of the exposed matter.  As the 
wavelengths increase, the energy-matter interaction results in less ionization and more 
electron excitation (electrons jumping to higher energy levels) as the energy is absorbed by 
molecules.   
 
Although there are several classification schemes (Jagger, 1967), the ultraviolet spectrum 
may be most simply divided into four general classifications based on the wavelength's 
interaction with molecules:  (1) "vacuum ultraviolet" (VUV),  (2), ultraviolet “C” (UVC),  (3) 
ultraviolet “B” (UVB), and (4) ultraviolet “A” (UVA).  The VUV spectrum includes 
wavelengths <200 nm.  The most energetic wavelengths within the ultraviolet spectrum, 
VUV readily interacts with oxygen atoms and their interaction with organic molecules is 
detrimental even at low doses, however these wavelengths exist only in a vacuum due to the 
high energy.  UVC encompasses wavelengths between 200nm and 280nm.  This spectrum is 
also called the “germicidal” spectrum because of its biocidal effects on bacteria (Jagger, 
1967).  UVB ranges from 280nm to 315nm and is the wavelength responsible for "sun 
burning” the skin and the synthesis of Vitamin D (Goodsell, 2001).  UVA ranges from 
315nm to 400nm and is the primary light produced by black light fixtures (Stowe, 2005).  
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Both UVA and UVB are used in industry, e.g., to activate organic polymers used in 
laminates, production of medical devices (Stowe, 2005).  UVA and UVB, but not UVC, 
wavelengths, are long enough to pass through the earth’s atmosphere to the earth’s crust and 
can penetrate a short distance into the world’s oceans (Jagger, 1967).   
 
The focus of this review is UVC and its effect on microorganisms.  UVC is sometimes 
termed "ultraviolet germicidal irradiation" (UVGI) to distinguish it from the non-germicidal 
wavelengths, UVA and UVB (Kowalski, 2009).  UVC is biologically important because 
unsaturated organic compounds, i.e., compounds that are not fully saturated with hydrogen 
atoms or are composed of conjugated bonds, efficiently absorb wavelengths between 200nm 
and 280 nm (Jagger, 1967).  Conjugated bonds hold two electron pairs, each electron in the 
pair possesses an independent and opposite spin of equal energy.  When a photon of 
ultraviolet radiation energy strikes an electron, it is induced to rise to an excited (higher 
energy) level.  This disruption of stable electrons can travel the entire organic structure, 
raising a bonded electron out of a bonding pair, and result in an unstable conformation.  In 
conjugated bond-containing structures, the entire structure acts as a chromophore, i.e., the π 
orbitals are shared throughout the ringed structure (Jagger, 1967).  Because of this, the entire 
structure absorbs the ultraviolet energy (photon) and this extra energy is drained off into the 
weakest bond, thereby causing conformational changes to occur (Jagger, 1967).   
 
Conjugated organic structures include nitrogen-containing ring structures such as pyridines, 
pyrimidines, flavins, and the aromatic amino acids (Jagger, 1967).  Because these structures 
act as chromophors, these wavelengths can also be used for nucleic acid analysis.  This 
process is based on the difference in absorption between nucleic acids and proteins.  
Essentially, this methodology relies on that fact that peptide bond exhibits double-bond 
characteristics, whereas aromatic amino acids absorb ultraviolet (Jagger, 1967).  Figure 1 
shows the structure of conjugated bases within genetic material.  Figure 2 shows the structure 
of conjugated bases within the aromatic amino acids. 
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Figure 1.  UV254-labile organic structures in nucleic acids.  (Cacycle, 2007.  Property in 
public domain downloaded June 2010.)  
.   
 
 
   
Phenylalanine Tyrosine Tryptophan 
 
 
Figure 2. UV254-labile organic amino acids.   
 
MEASURING ULTRAVIOLET:  RADIOMETRY AND ACTINOMETRY 
Measurement is the heart of science and the basis upon which effects are evaluated.  There 
are two basic ways to measure the intensity and duration of ultraviolet radiation: radiometry 
and actinometry.   
 
Radiometry measures irradiance, the ultraviolet energy striking a surface from all forward 
angles at a point in time expressed as energy (watts) per unit area (Bolton and Linden, 2003).  
A radiometer is a sensor with an electronic readout device that displays the sensor readings.  
Sensors are wavelength-specific and have a cosine response that accounts for the incident 
  
Pyrimidine          Purine 
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angle of the light source as it strikes the sensor’s surface.  (Note: to ensure accurate 
ultraviolet measurements, radiometers need to be calibrated annually.)  Since ultraviolet 
sensors typically have a measurement area of one square centimeter, the amount of 
ultraviolet energy arriving at the surface is commonly measured in watts per m2 or mW per 
cm2.  In biological experiments it is necessary to account for both the intensity of the 
ultraviolet light energy (irradiance) and the length of exposure (time).  Therefore, 
radiometers are often equipped to measure cumulative exposure over time (mWs per cm2).   
 
Actinometry is a second method of measuring ultraviolet light energy.  Actinometry is based 
on chemical systems that undergo light-induced reactions at specific wavelengths for which 
the quantum yield is accurately known (Kuhn et al., 2004).  The quantum yield is a measure 
of molecular UV-absorption efficiency of a chemical and is described as the ratio of the 
number of chemical changes per unit time to the number of photons absorbed per unit time 
(Kuhn et al., 2004): 
 
 Ф  = Nc/Np         (1) 
 
Where: 
 Ф  = Quantum yield 
 Nc  = Number of molecules chemically reacting 
 Np  = Number of photons absorbed 
 
For example, iodide/iodate solution is an actinometer commonly used in the UVC spectrum 
because it absorbs energy between 200nm and 300nm.  The concentration of the product 
(triiodide) is directly proportional to the intensity, i.e., the number of photons absorbed, as 
measured on a spectrophotometer at 352nm (Rahn et al., 2005).  This is not to be confused 
with the radiometric ultraviolet dose which is independent of photon absorbance.   
 
There are important differences between the two methods and it should be recognized that 
each provides results based upon different parameters.  Actinometry is the preferred method 
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of measuring ultraviolet exposure in the field of photochemistry and photochemists express 
ultraviolet exposure in units of quantum yield.  Actinometry is neither convenient nor 
practical in photobiology and photobiologists measure ultraviolet using radiometry and 
express exposure in joules per cm2.  This difference in the expression of ultraviolet exposure 
units presents a fundamental problem in communicating results across disciplines.   
 
Ultraviolet is also sometimes described in terms of fluence rate, the energy (mW) passing 
through a cross-sectional area (cm2), with ultraviolet dose defined as the fluence rate per unit 
time in seconds (s), i.e., mWs per cm2 (Bolton, 2000).  A joule is expressed as energy × time, 
therefore ultraviolet dose is expressed as joules per cm2.  Because radiometers are in 
common use and more readily implemented than chemical actinometry, the term "ultraviolet 
dose" is sometimes used interchangeably with "fluence rate", regardless of the object’s 
ability to absorb ultraviolet.  Therefore, depending upon the field or discipline, the 
terminology used may not strictly conform to the definitions of the International Union of 
Pure and Applied Chemistry Working Party on Ultraviolet Disinfection (Bolton and Linden, 
2003).   
 
CONSIDERATIONS IN EXPERIMENTAL UV254 PHOTOBIOLOGY  
Photobiology describes the interaction between light and living matter.  Bolton and Linden 
(2003) outlined the basic requirements in the design of bench scale ultraviolet inactivation 
apparatus for wastewater experimentation, but these standards also apply to other types of 
ultraviolet experimentation involving inactivation of microorganisms. Specifically, bench-
scale ultraviolet inactivation experiments should be reproducible across laboratories and 
contain the basic elements of good experimental design.   Results that provide a foundation 
for forward progress will also use accepted terminology to describe the experimental design 
and results.  Thus, the terminology presented in this review is based on the recommendations 
of the International Union of Pure and Applied Chemistry Working Party on Ultraviolet 
Disinfection (Bolton and Linden, 2003).   
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The single most significant physical factor in UV254 inactivation is lamp design and 
performance (VanOsdell and Foarde, 2002).  In microbiology, the majority of work 
involving photobiology involves "germicidal" UVC, with UV254 being the wavelength 
considered to possess the strongest inactivating effect.  Importantly, VanOsdell and Foarde 
(2002) noted that for a UV254 system to efficiently inactivate pathogens, the bulb design (type 
of quartz, internal gas composition, operating temperature, ballast type) must be matched 
with the environmental conditions (temperature and relative humidity).   
 
The first mercury vapor arc lamp was developed by Wheatstone in 1835 (Kowalski, 2009).  
Other metallic gases (zinc, iron, or xenon) can be energized into ultraviolet emission, but 
excited mercury gas is the most efficient ultraviolet emitter and is used extensively in UV254 
bulbs.  Mercury gas ultraviolet emitters are produced as low-, medium-, and high-pressure 
bulbs.  Low- and medium-pressure mercury lamps consist of electrodes that produce 
electrons that collide with mercury atoms causing them to emit photons, predominately at 
253.7 nm (Jagger, 1967).  High-pressure mercury lamps, while similar in design, use 
electrodes capable of high voltage, thus allowing for an increase in the efficiency of emitted 
photons (Jagger, 1967).   
 
Low-pressure bulbs (internal pressure of less than 1 bar) operate at a low surface temperature 
and emit monochromatic (UV254) wavelengths (Figure 3).  Medium-pressure bulbs (internal 
pressure slightly higher than 1 bar) operate at higher surface temperature and emit 
polychromatic light (Figure 3).  To eliminate undesired ultraviolet wavelengths, the synthetic 
quartz containing the vaporized mercury atoms can be treated with wavelength-dependant 
ultraviolet-absorbing components that block specific wavelengths from exiting the bulb.  
Proper temperature control must be maintained when using medium-pressure vapor lamps 
because the lamps produce heat and the output (irradiance) of these lamps is temperature-
sensitive.  As a result, these lamps require additional power to increase the internal 
temperature and pressure of the lamp.  This increased temperature allows for an increased 
ultraviolet light spectrum, but until the bulbs reach operating temperature, their output 
fluctuates.  For that reason, under experimental conditions, a shutter system is needed so that 
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Figure 3.  Spectral output of low- and medium-pressure UV lamps.  Low-pressure 
bulbs (solid line) are monochromatic (UV254) whereas medium-pressure 
lamps (dashed line) are polychromatic (200 nm to 400 nm).  Figure adapted 
from Bolton and Linden, 2003.  Reprinted by permission of the publisher.   
 
light-emitting bulbs reach peak performance prior to target exposure (Bolton and Linden, 
2003).    
 
Under experimental conditions, the structure of the ultraviolet-emitting apparatus must be 
designed to provide a spatially homogeneous field of irradiation.  This can be accomplished 
through the use of a collimating tube (Bolton and Linden, 2003; Shen et al., 2005; Thurston-
Enriquez et al., 2003).  However, depending on the experiment, a collimating tube may not 
be required.  That is, in the absence of reflected ultraviolet energies and with irradiance from 
one plane only, the cosine sensors will account for any incident irradiation.  Sensors for 
measuring ultraviolet and holding treatment samples should be secured to a thermally and 
physically stable exposure stage.  For accurate measurements of ultraviolet exposure, sensors 
must be placed at the same distance from the energy source as the irradiated sample and 
absorbance of ultraviolet by the sample matrix must be taken into account.  Bolton and 
Linden (2003) consider it necessary to stir the solution to ensure uniform ultraviolet dose, but 
small volumes or a matrix that does not readily absorb ultraviolet need not be stirred.   
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Lambert-Beer law          In brief, this law states that some of the UV254 energy to which the 
target is exposed will be absorbed by the surrounding environment and this absorption must 
be taken into account.  For microorganisms in suspension (liquid or aerosol), the average 
UV254 intensity may be calculated as follows (Thurston-Enriquez et al., 2003):    
  
 Iaverage = I0(1 – e-aeL) / aeL        (2) 
Where: 
 Iaverage = average UV254 intensity (milliwatts per square centimeter) 
 ae  = absorbance of the virus suspension to the base e  
 I0 = UV254 intensity after passing through solution  
 L  = depth (centimeters) of the solution irradiated by the UV254 energy.  
 
For liquid media, the amount of ultraviolet energy absorbed by the solution can be 
determined by measuring the amount of ultraviolet that passes through the matrix using a 
quartz cuvette equal to the depth of the sample (Lambert-Beer’s Law).  Jagger (1967) 
provides information on the absorption coefficients for various solutions, but only empirical 
data will provide the researcher the information to necessary to determine if stirring is 
necessary. 
 
MECHANISM OF ULTRAVIOLET INACTIVATION  
Inactivation of microorganisms by ultraviolet is initiated at the quantum level.  The quantum 
yield is the number of photons, or the photon density, impacting a surface area.  Each photon 
carries an amount of energy called a quantum (ε) determined from quantum mechanics 
(Jagger, 1967, and Kowalksi, 2009).  
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 ε = (h)(ν)          (3) 
Where: 
 ε  = Energy in one photon 
 h  = Planck’s constant, 6.626 x 10-34 joules (J) 
 ν  = Frequency in hertz (Hz) 
 
Much of the quantal information was determined in the 1960s, when ultraviolet researchers 
focused on the mechanism of inactivation.  During this time, researchers estimated the 
quantum yields required for dimerization of nucleic acids (Kleczkowski, 1963; Shore, 1956).  
Kowalski (2009) calculated that ultraviolet at a wavelength of 253.7 nm has a frequency of 
1.18 x 1015 Hz and 7.819 x 10-19 J of energy per photon.  It follows that each joule contains 
1.279 x 1018 photons and an ultraviolet dose of one millijoule per cm2 will produce 1.279 x 
1015 photons per cm2.  Thus, a microorganism with a diameter of  0.1 micron, i.e., a cross-
sectional area of 3.14 x 10-14 m (3.14 x 10-12 cm), will be subjected to the passage of 
approximately 401,000 photons per second (Kowalski, 2009).   
 
Ultraviolet energy at 254nm readily affects the double-bond stability between adjacent 
carbons.  There are two types of molecular bonds occurring in conjugated organic structures, 
the sigma (σ) orbitals and the Pi (π) orbitals.  The higher energy sigma orbitals (shorter wave 
function) are located closer to the nucleus of the two bonded atoms.  The Pi orbitals are of 
lower energy and are nonlocalized about the bonded pair.  The lower energy Pi orbitals are 
more stable and, therefore, have longer wave function (Kowalski, 2009).  Conjugated ring 
structures, like pyrimidines, purines, and aromatic amino acids have large, non-localized Pi 
orbitals (Smith and Hanawalt, 1969).  When an incoming UV254 photon strikes a Pi orbital, 
the photon’s energy is converted to vibrational energy (Kowalski, 2009).  If this vibrational 
energy is sufficient, the Pi orbital is pushed into a transient unstable state that exists for a 
femtosecond (10-15).  This unstable state must return to the ground state either by dissipation 
of the energy or through modification of the bond by rotation (Kowalski, 2009).   
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Unsaturated organic compounds are essential to cell reproduction and cell metabolism. 
Unsaturated organic compounds vulnerable to UV254 inactivation include pyrimidines, 
purines, and flavin.  Pyrimidines provide the basic structure for nucleobases uracil (a 
component of tRNA), thymine (a component of DNA and tRNA), and cytosine (a component 
of DNA and RNA).  Purines provide the basic structure for nucleobases adenine and guanine 
(in DNA and RNA) and the aromatic amino acids, phenylalanine and tyrosine.  Flavin is an 
unsaturated organic compound found in the aromatic amino acid tryptophan and is the basic 
structure of flavin adenine dinucleotide (FAD), a molecule necessary for metabolic redox 
reactions.   
 
Nucleic acids are composed of bases, sugars and phosphates.  Photons affect DNA and RNA 
by inducing molecular transformation, i.e., photoproducts, of the genetic material.  The 
sugars and phosphate groups do not absorb wavelengths above 210nm, but conjugated bases 
have peak absorption of ultraviolet light energy at 260nm, with pyrimidines being 10 times 
more sensitive to UV254 than purines (Jagger, 1967).  It follows that uracil and cytosine in 
RNA and thymine and cytosine in DNA are the targets of UV254 inactivation.  Whether the 
target is RNA or DNA, the mechanism of UV254 inactivation is hydration of the base or base 
dimerization (Jagger, 1967).  There are 6 possible photoproducts induced by ultraviolet: (1) 
thymine-thymine dimer, (2) cytosine-cytosine dimer, (3) cytosine-thymine dimer, (4) uracil-
uracil dimer, (5) uracil-thymine dimer, and (6) uracil-cytosine dimer (Kowalksi, 2009).  The 
photoproducts requiring the least energy are the thymine-complex dimer and the uracil-
complex dimer (Jagger, 1967; Kowalski, 2009).  Cytosine hydrate, another UV254-induced 
photoproduct, occurs in RNA and single-stranded DNA (Smith and Hanawalt, 1969).  This 
structure requires more energy, but is formed when UV254 irradiation of cytosine yields 6-
hydroxy-5,6-dihydrocytine (O'Donnell et al., 1994).  In DNA, the thymine dimer is the 
photoproduct with the highest quantum yield (Kowalski, 2009).  These dimers occur when 
the hydrogen bonds linking the thymine bases are lost and the respective 5 and 6 carbon 
atoms are cross-linked.  A representation of a generic dimer is shown in Figure 4. 
 
13 
The biological effects of UV254 exposure are reversible.  In bacterial cells, dimer formation is 
reversible via absorption of wavelengths between 300nm and 500nm (photo reactivation) or 
by photolyase enzymes that split the dimers.  DNA viruses utilize host cellular polymerase 
enzymes to excise dimers and replace the damaged DNA (Kowalski, 2009).  Generally, 
viruses do not produce their own photolyases with the exception of fowlpox virus, the only 
virus known to code for its own photolysase enzyme production (Srinivasan et al., 2001).   
 
 
 
 
Figure 4.   Dimer formation between adjacent pyrimidines or purines nucleobases.  
Illustration by D. Herring (http://earthobservatory.nasa.gov/Library/UVB).    
 
The ultraviolet inactivation of microorganisms can be achieved with either monochromatic or 
polychromatic emitters.  Monochromatic lamps producing primarily UV254 are routinely used 
to inactivate microorganisms.  Compared to monochromatic lamps, polychromatic lamps 
may possess greater efficiency (Linden et al., 2007).  For example, Eischeid et al. (2009) 
reported low-pressure monochromatic ultraviolet lamp doses of 30mJ per cm2, 50 mJ per 
cm2, and 80mJ per cm2 resulted in 2 log, 3 log, and 4 log reduction of adenovirus type 2 
virus, respectively.  In contrast, doses of 10 mJ per cm2 and 25 mJ per cm2 from medium-
pressure polychromatic ultraviolet lamps resulted in 2.5 log and 4.5 log adenovirus 
reductions, respectively.  Presumably these differences in inactivation reflected the fact that 
monochromatic ultraviolet wavelengths only caused genetic damage, whereas polychromatic 
wavelengths also affected aromatic proteins.  That is, the structure and function of microbial 
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proteins depend on their primary, secondary, and tertiary structures, which reflect their 
constituent amino acids.  It is estimated that one in 10 amino acids are susceptible to 
photochemical processes and, hypothetically, the photochemical alternation of any of these 
amino acids could affect protein structure and function (Jagger, 1967).  Therefore, the 
efficiency of ultraviolet inactivation could be increased though the use of medium- or high-
pressure polychromatic bulbs, but this gain is generally offset by the additional expense of 
operating this equipment.  
 
PRINCIPLES OF ULTRAVIOLET INACTIVATION 
The inactivation kinetics of ultraviolet can be described as a first order chemical reaction.  
That is, the amount of reagent (ultraviolet irradiance) will equal the amount of product 
(modified conjugated bonds) in a given time period.  The Stark-Einstein Law states that if a 
photon is absorbed, then only one photon should be required for the formation of one 
photoproduct.  This law is the foundation of the “one-hit” (first order) kinetics that have 
historically been used to describe UV254 inactivation (Hiatt, 1964; Kowalksi, 2009; Qualls 
and Johnson, 1983; Thurston-Enriquez et al., 2003).   
 
Grotthus-Draper Law          The Grotthus-Draper Law states that photons must be absorbed 
for a photochemical reaction to occur (Kowalski, 2009).  Following this line of thought, 
Bolton and Linden (2003) suggest that the term “ultraviolet dose” should be used to describe 
the total energy absorbed by the target.  Problematically, energy striking an object is not 
necessarily absorbed by the object (Jagger, 1967) and absorbed photons may not produce a 
photochemical reaction (Kowalski, 2009).  Currently the only method to measure the 
absorptive efficiency of a conjugated organic molecule is actinometry.   
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Bunsen-Roscoe Reciprocity Law          The Bunsen-Roscoe Reciprocity Law states that 
microbial inactivation is dependent upon dose and dose is the product of ultraviolet intensity 
expressed in mW per cm2 and exposure time expressed in seconds (Riley and Kaufman, 
1972).   
 
 D = I × T          (4) 
Where:   
 D  = Ultraviolet dose 
  I  = Irradiance (intensity) in mW per cm2 
 T  = Exposure time in seconds 
 
The Bunsen-Roscoe law is important and relevant to microbial inactivation because it shows 
that, although the ultraviolet irradiance drops as the target moves further away from the 
source (except in a vacuum), the desired ultraviolet dose can be achieved by increasing the 
exposure time.  This law is fundamental because it allows for the comparison of results from 
experiments using different ultraviolet equipment types, wattages, and conditions, when the 
exposure time is known.   
 
Chick's Law          Chick's Law states that as disinfectant contact time (t) increases, the ratio 
of viable microorganisms (Nt) to the total (N0) microbes at time zero decreases.  Chick's law 
was originally used to describe the relationship between chlorine and the inactivation of 
microorganisms in wastewater (Rubin and Elmaraghy, 1977).  Figure 5 illustrates first order 
inactivation kinetics where absorbance of one photon results in inactivation.   
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Figure 5.   Effect of disinfectant contact time on the proportion of remaining viable 
microorganisms (Chick’s Law).  Non-transformed data are show at left; 
log10 transformed data on the right.   
 
Since the 1950s, inactivation constants (k) derived using Chick's Law have been used to 
measure the sensitivity of microorganisms to ultraviolet inactivation, with larger inactivation 
constant values (larger slope) indicative of greater susceptibility to ultraviolet inactivation. 
The following equation is a modification of the formula used by Tseng and Li (2005) to solve 
for the inactivation constant (k).    
 
 k = [log10 (Nt / N0)] / Dose            (5) 
Where: 
 k = the inactivation constant 
 N0 = quantity of microbes at time zero  
 Nt = quantity of microbes at UV254 exposure time "t"  
 Dose = ultraviolet light dose 
 
ONE-STAGE VS TWO-STAGE INACTIVATION  
Hiatt (1964) published the first work detailing the kinetics of microbial activation and noted 
that the “first order” inactivation model, i.e., the single-hit hypothesis proposed by the Stark-
Einstein Law and described by a single inactivation constant (k), was accurate only if the 
exposed viral population was homogenous and inactivation did not require cumulative 
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damage.  Hiatt (1964) also described the classical inactivation curve dynamics of 
"shouldering" and "tailing".  “Shouldering” refers to an increase of UV254 dose with no 
corresponding increase in microbial inactivation, whereas “tailing” is a decrease in UV254 
dose with no corresponding decrease in microbial inactivation (Hiatt, 1964).  In contrast to 
the one-stage inactivation model, the two-stage model proposes that exposure of microbial 
populations to an inactivant may reveal two subpopulations:  one subpopulation (f) more 
susceptible to inactivation and a second subpopulation (1 – f) more resistant (Cox, 1976; 
Kowalski et al., 2002; Hiatt, 1964).   
 
ܔܗ܏૚૙ ۼܜ ൌ ܔܗ܏૚૙ۼ૙ ൅ ܔܗ܏૚૙ሾሺ૚ െ ࢌሻ · ૚૙ି۹૚·۲ܗܛ܍ܜ ൅ ࢌ · ૚૙ି۹૛·۲ܗܛ܍ܜሿ  (6) 
where: 
 Nt   = quantity of virus in the test sample after treatment with Doset   
 N0  = quantity of virus in the unexposed control sample,  
 f  = the resistant fraction of the total initial virus population with inactivation 
rate K2  
 (1 – f ) = the susceptible virus population fraction with inactivation rate K1 
 k 1 = the inactivation rate of the inactivation curve for the "fast decay population" 
 k 2  = the inactivation rate of the inactivation curve for the "resistant population" 
 Doset = UV254 intensity × time 
 
In practice, the two-stage inactivation analysis should be utilized when the statistical analysis 
indicates that the data are better described by two-stage vs. one-stage inactivation kinetics. 
 
APPLICATIONS OF ULTRAVIOLET TO THE INACTIVATION OF 
MICROORGANISMS 
In the laboratory          The classic application of ultraviolet is the inactivation of 
microorganisms in biological safety cabinets.  In many laboratories, turning on the ultraviolet 
lamp after using the cabinet is standard operating procedure.  The current version of the 
National Science Foundation (NSF) International Standard 49 (Section 5.25.2) does not 
mandate the use of ultraviolet in biosafety cabinets (Meechan and Wilson, 2006).  Further, 
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the Centers for Disease Control and Prevention states that the use of ultraviolet in biosafety 
cabinets is neither recommended nor necessary (CDC, 2009).  Ultraviolet inactivation of 
microorganisms on surfaces is ancillary to standard chemical disinfection and should not be 
relied upon as the sole method of disinfection. 
 
Food processing          In the food-processing industry, germicidal ultraviolet has shown 
potential for the surface disinfection of fresh-cut fruit and vegetables.  In studies on carrots 
(Mercier et al., 1993), grapes (Nigro et al., 1998), sweet potatoes (Stevens et al., 1999), and 
spinach leaves (Artés-Hernéndez et al., 2009), UVC treatment was shown to reduce product 
deterioration and prolong storage life.  Alone or in combination with ozone, ultraviolet 
reduced the number of viable microorganisms in water used to wash fresh-cut onion, 
escarole, carrot, and spinach (Selma et al., 2008).  Ultraviolet may provide a viable 
alternative to chemical sanitizers, e.g., titanium dioxide (TiO2) or chlorine.  Currently, there 
is interest in developing non-thermal methods for the sterilization of juices; an objective in 
which UVC may play a role (Guerrero-Beltran and Barbosa-Cánovas, 2005).   
 
Water treatment          The application of ultraviolet to food preservation is a relatively 
recent development, but the use of ultraviolet for the treatment of water has an extensive 
history:  the first system for ultraviolet treatment of potable water went into operation in 
Marseilles, France in 1910 (Kowalski, 2009).  Ultraviolet treatment of water was not widely 
implemented at the beginning of the 20th century for a variety of reasons, including high 
operating costs, issues with equipment reliability and maintenance, and the availability of 
cost-effective, chemical water treatment systems (Wolfe, 1990).  Ultraviolet is regarded as 
broadly effective against all human pathogens (bacterial, viral, and protozoal) transmitted in 
water (Hijnen et al., 2006) and guidelines for the treatment of waste water and potable water 
with ultraviolet have been established (Environmental Protection Agency, 2003).  UV 
treatment of water (potable and wastewater) is increasingly common because the technology 
is readily available, the process is effective against a wide range of microorganisms, 
overdose is not possible, chemical residues or by-products are avoided, and water quality is 
unaffected (Hijnen et al., 2006: Wolfe, 1990).   
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Bioaerosols          A wide variety of fungal, bacterial, and viral pathogens may be transmitted 
by airborne droplets or droplet nuclei (Blachere et al., 2007; Tang et al., 2006).  Airborne 
pathogens of humans include major emergent and re-emergent agents, e.g., Mycobacterium 
tuberculosis, influenza viruses, severe acute respiratory syndrome coronavirus, Aspergillus 
spp., Legionella spp. (Douwes et al., 2003; Escombe et al., 2007; Wong and Yuen, 2006).  
Likewise, some of the most economically significant pathogens of animals are transmitted 
via aerosols, e.g., foot-and-mouth disease virus and porcine reproductive and respiratory 
syndrome virus (Alexanderson et al. 2002; Hermann et al., 2009).  Regardless of the actual 
level of risk bioaerosols present to the public, events of recent history have raised society's 
awareness and concern.  In the market place, ultraviolet emitters designed for installation in 
residential air handling system are commercially available, despite the fact that data on the 
efficacy of these systems is sparse (Environmental Protection Agency 2006a, 2006b, 2006c, 
2006d).   
 
Ultraviolet has successfully reduced the concentration of airborne microorganisms in targeted 
applications.  Berg et al. (1991) found that ultraviolet irradiation of air in operating rooms 
during surgery significantly reduced the number of viable airborne bacteria collected at the 
edge of the surgical site.  Likewise, installation of ultraviolet in air-handling units and 
ventilation systems reduced the concentration of airborne bacteria and fungi in indoor air 
(Levetin et al., 2001; Menzies et al., 1999; Menetrez et al., 2010).   
 
Moving beyond narrowly focused applications, the use of ultraviolet for the routine 
inactivation of airborne microorganisms faces severe technical challenges.  In the first place, 
the inactivation kinetics of most airborne pathogens is not known for the range of 
environmental conditions (temperature and relative humidity) under which such a system 
would need to function.  This is a significant deficit because environmental conditions are 
known to affect ultraviolet, e.g., as relative humidity increases, ultraviolet becomes less 
efficient (Ko et al., 2000; Lai et al., 2004; Peccia et al., 2001; Tseng and Li, 2005; VanOsdell 
and Forde, 2000; Walker and Ko, 2007).  Thus, acquiring baseline exposure doses in order to 
target ultraviolet exposure levels is the first priority.  Beyond this, delivery of the inactivating 
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dose uniformly and consistently to large volumes of air is a significant challenge given the 
current state of the technology.  At present, ultraviolet inactivation of bioaerosols can only be 
considered one part of an overall biocontainment plan, rather than a stand-alone solution 
(Memarzadeh et al., 2010).   
 
GENERAL CONCLUSIONS 
The use of ultraviolet for the inactivation of microorganisms is appealing because it is a 
familiar, commercially-available technology that does not involve the use of chemicals.  
Some applications are well developed, e.g., water treatment.  Some show future promise, 
such as applications in food processing.  One highly desirable application, the routine use of 
ultraviolet for the inactivation of microorganisms in aerosols, will require extensive 
development and ultimately may only function effectively in tandem with other technologies, 
e.g., photocatalysis or filtration systems.    
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 CHAPTER 2.  VALIDATION OF THE "CONTINUOUS STIRRED-TANK 
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AIRBORNE TARGETS IN A DYNAMIC AEROSOL TOROID 
 
A paper submitted to the Journal of the Royal Society Interface 
 
Timothy D. Cutler, Chong Wang, Steven J. Hoff, Jeffrey J Zimmerman 
 
ABSTRACT 
In aerobiology, dose-response studies are used to estimate the risk of infection to a 
susceptible host presented by exposure to a specific dose of an airborne pathogen.  In the 
research setting, host- and pathogen-specific factors that affect the dose-response continuum 
can be accounted for by experimental design, but the requirement to precisely determine the 
dose of infectious pathogen to which the host was exposed may be challenging.  By 
definition, quantification of viable airborne pathogens is based on the culture of 
microorganisms, but some airborne pathogens are transmissible at concentrations below the 
threshold of quantification by culture.  In this paper we present an approach to the calculation 
of exposure dose at microbiologically unquantifiable levels using an application of the 
“continuous-stirred tank reactor (CSTR) model” and the validation of this approach using 
rhodamine B dye as a surrogate for aerosolized microbial pathogens in a dynamic aerosol 
toroid (DAT).   
 
1.0  INTRODUCTION 
Airborne transmission poses a major challenge to the control of human and animal 
pathogens.  For humans, airborne transport has been linked to the transmission of 
Coccidioides immitis (CDC 2009), Mycobacterium tuberculosis (de la Rua-Domenech 2006), 
Legionella spp. (Diedern 2007), smallpox virus (Feigel et al. 2006), and a variety of other 
pathogenic fungi, bacteria, and viruses (Douwes et al. 2007; Fransworth et al. 2006; Nicas et 
al. 2005; Stärk 1999).  For animals, some of the most economically significant pathogens are 
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transmitted in bioaerols, e.g., foot-and-mouth disease virus (Alexandersen et al. 2002), 
classical swine fever virus (Weesendorp et al. 2008), and porcine respiratory and 
reproductive syndrome virus Dee et al. 2006).  Of importance to both human and animal 
health are major zoonotic pathogens transmitted via aerosols, including influenza virus 
(Loosli et al. 1943; Wong and Yuen 2006), severe acute respiratory syndrome (SARS) 
coronavirus (Booth et al. 2005), Yersinia pestis (Nicas et al. 2005), Bacillus anthracis 
(Inglesby et al. 1999) and others. 
 
In aerobiology, dose-response curves are useful for describing the probability (y-axis) that a 
specific dose (x-axis) of an airborne pathogen will produce infection in a susceptible host 
(Douwes et al. 2007; Pillai and Ricke 2002).  Under experimental conditions, dose-response 
curves can be derived by individually exposing susceptible animal hosts to a known quantity 
of pathogen and then monitoring each animal for evidence of infection under conditions that 
preclude the possibility of infection from all other sources (French et al. 2002; Hermann et 
al. 2009).  The proportion of individuals that become infected at each dose provides the raw 
data upon which the dose-response curve is based.   
 
A variety of statistical techniques may be used to analyze the dose-response relationship 
(Hubert 1977), with the ID50, the dose required to infect 50% of the population, being the 
most useful summary statistic of the dose-response for any defined pathogen-host system 
(Spouge 1992; Ward and Akin 1984).  A standard dose-response curve is defined by four 
parameters: the baseline (bottom), the maximum response (top), the slope of the curve, and 
the mid-point of the curve (Motulsky and Christopoulos 2003), but the exact parameters of a 
dose-response curve depend on the strain or isolate of the pathogen (Ward and Akin 1984), 
the host species (Thurston-Enriquez 2003), and specific host factors, such as age and immune 
status (Jani et al. 2008).   
 
In the research setting, host- and pathogen-specific factors that affect the dose-response curve 
can be accounted for by careful experimental design.  A larger challenge is the requirement 
to determine the dose of infectious pathogen to which the host was exposed.  Estimation of 
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exposure dose requires measurements on the total volume of air respired by the host and the 
concentration of viable airborne pathogen, e.g., liters of air respired by the susceptible host × 
pathogen concentration per liter of air = exposure dose.  In domestic animals, total respired 
air can be measured using appropriate spirometric instrumentation (Hermann et al. 2009).   
 
Estimates of the concentration of infectious airborne pathogen are often more difficult to 
achieve.  By definition, quantification of viable airborne pathogens is based on techniques 
that require the microorganism to replicate in culture.  Culture-based methods are less 
analytically sensitive than contemporary molecular techniques, e.g., polymerase chain 
reaction (PCR), but molecular assays cannot substitute because they do not differentiate 
between infectious and non-infectious microorganisms (Douwes et al. 2007; Ward and Akin 
1984).  If the pathogen is not highly transmissible, i.e., if transmission requires a large 
exposure dose, the determination of the dose-response curve may be achieved despite the 
requirement to quantify infectious microorganisms in culture.  Not infrequently, airborne 
pathogens are transmissible at concentrations below the threshold of quantification by 
culture.  Under these circumstances, the exposure dose, and hence the probability of 
transmission, is incalculable (Gillespie et al. 1996; Pallai and Ricke, 2003).  In this paper we 
present an engineering approach to the calculation of exposure dose at microbiologically 
unquantifiable level.   
 
The continuous-stirred tank reactor (CSTR) is a vessel characterized by steady-state and 
uniform internal conditions due to mixing (Hill 1997).  The reactions and processes occurring 
within the CSTR may be well-defined for the conditions of the vessel.  For example, the 
concentration of a target within a CSTR can be predicted at any time (t) using the equation: 
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)–1(==))/(–1(= xeinCC
VQteinCtC
––
 
Where: 
 tC   = target concentration at time = t 
 inC  = target input concentration at time = 0 
 t   = time  
 Q   = flow rate (incoming rate = outgoing rate) 
 V   = volume of the CSTR 
 e   = the base of natural logarithm (Euler's number) 
 x   = one complete exchange of the volume of the CSTR 
 
 
Table 1.   Target concentration as a function of the number of complete exchanges of a 
continuous-stirred tank reactor (CSTR)  
 
Exchange ( )x 1 
inC
tC  
Target retained  
in the CSTR (%) 
1 1 – e-1 37.0 
2 1 – e-2 14.0 
3 1 – e-3 5.0 
4 1 – e-4 1.8 
5 1 – e-5 0.7 
 
  1 x = one complete exchange of the volume of the CSTR 
   
CSTRs are widely used in a variety of industrial, chemical, and biological applications, 
including bioreactors, fermentation vessels, and wastewater treatment.  Goldberg et al. 
(1958) introduced the use of a continuously rotating drum ("dynamic aerosol toroid") to 
experimental aerobiology as a method to maintain and study infectious particles suspended in 
aerosols over time.  The rotating dynamic aerosol toroid (DAT) housed in an environment 
that preserves the pathogen's infectivity, e.g., held at temperatures below freezing, is a CSTR.  
As such, the concentrations of the airborne components within the DAT can be predicted at 
time (t) if the exchange volumes are known.  This paper provides experimental evidence to 
support this concept and discusses the application of this approach to the problem of 
estimating the concentration of airborne pathogens at microbiologically unquantifiable levels. 
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2.0  MATERIALS AND METHODS   
2.1  Experimental design 
The objective of this experiment was to determine whether the CSTR-derived calculations 
could accurately predict the concentration of an airborne target in a DAT given known 
exchange volumes.  As a surrogate for an airborne microorganism, a fluorescent dye 
(rhodamine B) was aerosolized into a 400 liter DAT held at -4°C.  In 10 replicates, 12 air 
samples (200 liter each) were collected and the fluorescence measured.  These data were test 
for:  (1) a linear relationship between the concentration of rhodamine B removed 
( ))(,10log toutcM  and volume of aerosol removed ( )extractedV  and  (2) a significant 
difference between the theoretical and the observed rhodamine B regression lines.   
 
2.2  Experimental procedures 
A stainless steel 400 liter DAT was constructed based on the description provided by 
Goldberg et al. (1958).  For temperature control, the DAT was housed in a custom-built 
refrigeration unit (Carroll Coolers, Inc., Carroll, IA) maintained at -4˚C.  During operation, 
the DAT rotated at 4 RPM (Brother International Gearmotors, Bridgewater, NJ).  Three 
HEPA-filters (Fisher Scientific, Hampton, NH) were fixed to ports on the periphery of the 
DAT to allow for pressure equilibration during nebulization and impingement.  The entire 
system was disassembled and cleaned between each of the 10 replicates. 
 
In each replicate, approximately 50 ml of a 1X phosphate-buffered saline (PBS) (Thermo 
Scientific, Rockford, IL) solution containing 0.08% v/v rhodamine B (Sigma Chemical Co., 
St. Louis, MO.) and 0.1% v/v Antifoam A Emulsion (Sigma Chemical Co., St. Louis, MO.) 
was nebulized into the DAT using a 24-jet Collison nebulizer (BGI Inc., Waltham, MA) 
operating at 40 PSI.  According to the manufacturer's specifications, these parameters 
aerosolized the solution at a rate of 1.1 ml per minute and produced particles 1.9 μm in 
diameter.  After nebulization and prior to sampling, the cloud was allowed to equilibrate 
within the DAT for 60 minutes.  This allowed for complete mixing, sedimentation, and 
thermal equilibration of aerosolized rhodamine B.   
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Air samples were collected using sterile AGI-30 glass impingers (Ace Glass, Vineland, NJ) 
containing 20 ml of sterile 1X PBS (Thermo Scientific) as collection fluid.  Impingers were 
operated at a constant flow rate of 12.5 liters per minute using oil-less pumps (Fisher 
Scientific, Hampton, NH).  Pump performance was monitored using a vacuum pressure 
gauge (Cato Western Inc., Tucson, AZ).  Twelve 200 liter air samples were taken in 
succession, i.e., 6 complete evacuations of the DAT over a period of approximately 3.5 
hours.  All samples were maintained on ice until sampling was completed.  Thereafter, a 1.5 
ml aliquot of each sample was dispensed into a disposable ultraviolet transmissible cuvet 
(Fisher Scientific, Pittsburg, PA), allowed to warm to 20˚C, and the amount of rhodamine B 
dye in each sample measured using a fluorometer (Turner BioSystems Inc., Sunnyvale, CA) 
equipped with a green optical kit (Turner BioSystems Inc.).  Results were expressed as raw 
fluorescence units.  Prior to each replicate, the fluorometer was evaluated using a rhodamine 
B solid standard (Turner BioSystems Inc., Sunnyvale, CA).   
 
2.3  Analysis 
To predict the concentration of an airborne target (e.g., rhodamine B) within a CSTR as 
samples are drawn from the drum and replaced with filtered inlet air, a mass balance equation 
of the target's concentration in the drum can be written as: 
  
 (1) { }outcMincMamdt
amdrumcMd
,–,=
),(   
Where: 
 drumcM ,   = mass fraction of the target inside drum, kgtarget/kga 
 am   = mass of air inside drum, kga 
 t    = time, s 
 am   = mass flow rate of air through drum, kga/s 
 incM ,   = mass fraction of target entering drum, kgtarget/kga 
 outcM ,   = mass fraction of target leaving drum, kgtarget/kga 
 
33 
Based on the work of Goldberg et al. (1958), a DAT is a well-mixed vessel.  Therefore, the 
mass fraction of target leaving the drum is representative of the mass fraction inside the drum 
and can be stated as: 
 
 (2)   outcMdrumcM ,=,   
and equation (1) can be re-written as: 
 
      (3)  
 
Integrating equation (3) results in the common form of a perfectly mixed, but dynamically 
changing, mass fraction starting from a known initial mass fraction as: 
 
  (4)  
 
equation (4) states that the mass fraction of target in a perfectly mixed drum at any time (t) 
( )( )tM outc,  is a function of the initial concentration inside the ( )( )0=, tM outc drum and the 
exponential decay characterized by the mass of air inside the drum ( )am and the mass flow 
rate of air through the drum ( am ) assuming constant air density, equation (4) can be 
further described by: 
 
 (5)  
 
The starting point for determination of the concentration of the target at time (t) is the initial 
mass fraction within the drum ( )( )0=, tM outc .  Determination of target concentration 
requires sampling the air and subsequent sample analysis.  This extraction process results in 
an interruption of the initial mass fraction of the target. 
 
Equation (5) can be used to back-calculate the initial target mass fraction ( )0=t  within the 
drum from the initial extracted sample ( )1=t .  Thus, after the first sample extraction, some 
)/(
,, )0=(=)( a
mamtoutcoutc etMtM
– 
)/()0=(,=)(, drum
VextractedVetoutcMtoutcM
– 
{ }outcincaaoutc MMmdt
MMd
,,
, –=
)(

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known amount of drum air has been extracted ( )extractedV  resulting in a mass fraction of 
( )( )1, tM outc  providing an estimation of the initial mass fraction determined as: 
 
 (6) 
 
Equation (6) represents the initial mass fraction inside the drum.  Since the drum behaves as 
a well-mixed vessel, all subsequent sample extractions and the resulting mass fractions will 
obey the mixing model as given in equation (5) using the estimate for the initial mass fraction 
given in equation (6).  The final relationship becomes;  
 
  (7) 
Where: 
 )( 1, tM outc  = mass fraction from the first sampled extraction, kgtarget/kga 
 1, textractedV  = volume of drum air extracted for the first sample, liters 
 drumV   = fixed volume of the drum, liters 
 
Converting Equation 5 to log10 format, the mass fraction of the DAT can be mathematically 
represented as: 
 
 ( ) ( ) ( ) extracteddrumtoutctoutc VVeMM */log–log=log 100=,10,10  
Where: 
 ( )0=, toutcM  = concentration of rhodamine B at ( )0=t  
 ( )toutcM ,   = rhodamine B concentration at current time 
 extractedV  = the running total of the volume removed 
 drumV   = the total volume in container 
 e    = the base of natural logarithm (Euler's number).  
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This mathematical representation contained two assumptions:   
 1.  There is a linear relationship between ( )( )toutMc,log10 and extractedV ;  
 2.  The slope of the rhodamine B regression line was equal to – ( )drumVe /log10 .   
 
If both of these assumptions are true, then, ( )toutcM ,10log  is a linear function of 
extractedV  with intercept ( )0=,10log toutcM and slope ( )drumVe /log– 10 .  Thus, the linear 
relationship between ( )toutcM ,10log and extractedV  may be used to estimate the 
concentration of rhodamine B at any time along the regression line.  To validate Assumption 
(a), the concentration of rhodamine B (log10) in sequential air samples collected in each of 9 
replicates was analyzed using a simple linear regression model using the REG procedure in 
SAS® Version 9.2 (SAS® Institute Inc., Cary, NC) and the coefficient of determination (R2) 
was calculated.  To validate Assumption (b), the hypothesis that the average slope was equal 
to the theoretical slope ( )drumVe /log10  was tested using Students T.   
 
3.0  RESULTS 
A total of 10 replicates were attempted.  One replicate (number 4) failed because of technical 
problems experienced during the run.  For the remaining 9 runs, least square estimates of the 
intercept and slope as well as the coefficient of determination (R2) were calculated for each 
regression line (Table 2).  R2 described the proportion of response variation explained for by 
the linear model and ranges from 0 to 1, with a large R2 value indicative of a good fit of the 
linear model.  The mean R2 for the nine replicates was 0.93 with a standard deviation of 0.07.  
Overall, the linear regression line explained 93% of the variation in log10 transformed 
rhodamine B data.  The average slope of the 9 runs was not significantly different (p= 
0.1593) from the theoretical slope (-0.0011).  Therefore, these data support the conclusion 
that the linear relationship between ( )toutcM ,10log and extractedV  may be used to estimate 
the concentration of an airborne target in a DAT given known exchange volumes.    
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Table 2.   Parameters describing the linear relationship between the concentration of 
airborne rhodamine B and the volume of air extracted from a dynamic 
aerosol toroid  
 
Replicate R2 Slope Intercept 
1 0.96 -0.0013 3.47 
2 0.83 -0.0021 3.40 
3 0.96 -0.0030 3.16 
5 0.94 -0.0007 3.20 
6 0.95 -0.0011 4.07 
7 0.80 -0.0007 2.56 
8 0.97 -0.0012 4.08 
9 0.99 -0.0013 4.72 
10 0.98 -0.0016 4.70 
 
4.0  DISCUSSION AND CONCLUSIONS 
Successful airborne transmission occurs in three basic steps:  (1) aerosolization of the 
infectious agent;  (2) environmentally-dependent movement, dilution, and inactivation of 
airborne infectious particles; and  (3) contact, entry, and replication within a susceptible host 
(Stärk 1999).  From the perspective of prevention and control, the goal is to understand and 
model the transmission of airborne pathogens in order to design effective counter-measures.  
Both macro- and micro-level approaches are useful in meeting this objective.  That is, field 
data collected over the course of an outbreak may be useful for modeling the airborne spread 
of a pathogen within a population (Keeling et al. 2001).  Likewise, the basic steps and their 
components may be evaluated independently under controlled conditions to understand the 
contribution of each to the process of transmission (Hermann et al. 2009).  That is:  (1) 
quantify the rate at which the pathogen is excreted into the environment; (2) measure the rate 
of inactivation of the airborne infectious pathogen under specific environmental conditions; 
and (3) estimate the likelihood that exposure to a specific dose of the airborne infectious 
pathogen will produce a response (infection) in an individual host. 
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This study addressed the third step in this process and, in particular, the specific problem of 
deriving dose-response curves under experimental conditions in which transmission occurs at 
concentrations below the threshold of quantification for culture-based methods.  In this 
experiment, a tracer was used to model the behavior of an aerosolized pathogen in a rotating 
DAT.  Tracers, e.g., uranine, rhodamine B, and Bacillus subtilis spores, have been used 
extensively in experimental aerobiology (Verreault et al. 2008).  Songer (1967) aerosolized 
rhodamine B dye simultaneously with virus (Newcastle disease virus, infectious bovine 
rhinotracheitis virus, vesicular stomatitis virus, T3 bacteriophage) to track the physical loss 
of airborne virus within a DAT.  In an experiment of similar design, Hermann et al. 2007 
found no significant difference between the slopes of rhodamine B dye and porcine 
reproductive and respiratory syndrome virus RNA detected by quantitative PCR, i.e., the 
concentrations of rhodamine B and viral RNA declined in the DAT at the same rate.  Under 
the conditions of this experiment, the fact that the theoretical line and the experimental line 
were not significantly different provided evidence that physical loss did affect the outcome of 
the tracer values.  Thus, rhodamine B concentration has been shown to reflect target 
pathogen concentrations under conditions similar to those reported here.   
 
The physical parameters and experimental conditions of this study merit discussion.  This 
experiment was conducted in a 400 liter DAT rotated at 4 RPM.  However, a variety of DAT 
sizes and rotation speeds are reported in the literature, e.g., 140 liter (Songer 1967), 1000 liter 
(Adams et al. 1982), and 2,500 liter (Ehrlich 1964).  A review of the literature found no 
evaluation of the effect of DAT dimensions, volume, and rate of rotation on the behavior of 
suspended particles.  Therefore, it would be of value to confirm the results reported here 
using the described methodology.   
 
In this experiment, the environmental conditions were designed to preserve target pathogen 
infectivity.  In particular, the -4°C temperature at which the DAT was maintained would be 
expected to preserve the infectivity of a target pathogen indefinitely.  At temperatures above 
freezing, the slope of the airborne pathogen would diverge from the slope of the rhodamine 
B.  Therefore, the inactivation of the target pathogen over time would need to be accounted 
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for in the estimation of airborne pathogen concentration.  This is not an insignificant 
consideration because the rate of airborne pathogen concentration inactivation is affected by 
isolate (Kelling et al. 2001; Stärk 1999), the suspension medium (Benbough 1971), Ehlrich et 
al., 1964), temperature (Elazhary and Derbyshire 1979), relative humidity (Hermann et al. 
2007).  Therefore, it is preferable to avoid this complication by maintaining the DAT at 
temperatures below 0°C.    
 
In dose-response studies, the CSTR model solves the problem of estimating the exposure 
dose when the concentration of airborne pathogens at microbiologically unquantifiable 
levels.  Specifically, the linear relationship between ( )toutcM ,10log  and extractedV  may be 
used to estimate the concentration of a target at any point along the regression line.  Thus, 
( )toutcM ,10log  is a linear function of extractedV  with intercept ( )0=,10log toutcM  and 
slope ( )drumVe /log– 10 .  Therefore, under conditions similar to those reported here, the 
CSTR model solves the problem of estimating the exposure dose when the concentration of 
airborne pathogens is at microbiologically unquantifiable levels.   
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CHAPTER 3.  MEDIAN INFECTIOUS DOSE (ID50) OF PORCINE 
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VIA AEROSOL EXPOSURE 
 
Timothy D. Cutler, Chong Wang, Steven J. Hoff,  
Apisit Kittawornrat, Jeffrey J. Zimmerman 
 
A paper submitted to Veterinary Microbiology 
 
ABSTRACT 
The median infectious dose (ID50) of porcine reproductive and respiratory syndrome (PRRS) 
virus isolate MN-184 was determined for aerosol exposure.  In 7 replicates, 3-week old pigs 
(n = 58) respired 10 liters of airborne PRRS virus from a dynamic aerosol toroid (DAT) 
maintained at -4°C.  Thereafter, pigs were housed in isolation and monitored for evidence of 
infection.  Infection occurred at virus concentrations too low to quantify by microinfectivity 
assays.  Therefore, exposure dose was determined using two indirect methods ("calculated" 
and "theoretical").  "Calculated" virus dose was derived from the concentration of rhodamine 
B monitored over the exposure sequence.  "Theoretical" virus dose was based on the 
continuous stirred-tank reactor model.  The estimation of ID50 was modeled on the proportion 
of pigs that became infected using the probit and logit link functions for both "calculated" 
and "theoretical" exposure doses.  Based on "calculated" doses, the probit and logit ID50 
estimates were 1 x 10-0.13 TCID50 and 1 x 10-0.14 TCID50, respectively.  Based on "theoretical" 
doses, the probit and logit ID50 estimates were 1 x 100.26 TCID50 and 1 x 100.24 TCID50, 
respectively.  For each point estimate, the 95% confidence interval included the other three 
point estimates.  The results indicated that MN-184 was far more infectious than PRRS virus 
isolate VR-2332, the only other PRRS virus isolate for which ID50 has been estimated for 
airborne exposure.  Since aerosol ID50 estimates are available for only these two isolates, it is 
uncertain whether one or both of these isolates represent the normal range of PRRS virus 
infectivity by this route.   
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1.0  INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) virus was first isolated in 1991 in the 
Netherlands and shortly thereafter in the United States (Collins et al., 1992; Collins, 1991;  
Terpstra et al., 1991; Wensvoort et al., 1991).  The PRRS virus genome is polyadenylated, 
single-stranded, non-segmented, positive-sense RNA (Zimmerman et al., 2006).  Because it 
is an RNA virus, PRRS viruses are recognized as genetically and antigenically highly 
variable (Meulenberg et al., 1993; Meulenberg, 2000; Stadejeck et. al., 2006; Yoon et al., 
1999).  Understanding this variability in the context of immunity, clinical expression, and 
pathology has been a major area of research focus (Andreyev et al., 2000; Christopher-
Hennings, 2000; Corradi et al., 2005; Halbur et al., 1996a; Halbur et al., 1996b; Halbur et al., 
2002; Meier et al., 2004; Meulenberg, 2000; Murtaugh, et al., 1995; Murtaugh et al., 2002; 
Opriessnig et al., 2002; Stadejek et al., 2006).  In this paper we consider isolate variability in 
terms of infectivity. 
 
In June 2001, commercial swine herds in southern Minnesota USA reported outbreaks of 
abortion (1 to 45%), pre-weaning mortality (28 to 55%), nursery mortality (8 to 35%) and 
finisher mortality (7 to 14%) associated with PRRS virus infections (J Torrison, personal 
communication).  Among the PRRS viruses recovered from these outbreaks was an isolate 
found to possess a previously unrecognized restriction fragment length polymorphism pattern 
(RFLP 1-8-4), hence designated MN-184 (Cho et al., 2006; Faaberg et al., 2006).  Genetic 
analyses showed that MN-184 shared approximately 87% and 59% ORF5 nucleotide identity 
with VR-2332 and Lelystad viruses, respectively.  It was also determined that MN-184 
possessed the shortest PRRS virus genome sequenced to date (Han et al., 2006).  That is, the 
MN-184 genome consisted of 15019 nucleotides versus 15,111 nucleotides for the European 
prototype, Lelystad virus (GenBank M96262) and 15,182 nucleotides for the North 
American prototype, VR-2332 (GenBank EF536003) (Dee et al., 2010; Halburg et al., 
1996b).  In large part this was due to three deletions in the nsp2 region of ORF1a (replicase 
polyprotein) that resulted in the removal of 131 amino acids (Faaberg et al., 2006; Han et al., 
2006; Han et al., 2007).   
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Initial clinical signs in the field and subsequent controlled studies led to the classification of 
MN-184 as a highly pathogenic PRRS virus isolate (Cano et al., 2007; Cho et al., 2007).  In a 
direct comparison of five field isolates (MN-184, 171198-6, JA 142, SDSU 73, VR-2332), 
and three laboratory-attenuated viruses it was found that MN-184 induced the highest serum 
virus titers on day post inoculation (DPI) 7, 28, and 35 (Johnson et al., 2004).  Likewise, 
MN-184-inoculated pigs had the highest rate of mortality (50%) over the course of the study 
and the lowest mean body weight among all PRRS virus-challenged groups at DPI 49.   
 
The biodynamics of MN-184 have been describe in detail (Charerntantanakul et al., 2006; 
Cho et al., 2006; Cho et al., 2007; Dee et al., 2004; Dee et al., 2009; Otake et al., 2010).  Cho 
et al. (2006) compared shedding patterns in pigs infected with isolates MN-30100 and MN-
184.  Detectable aerosol shedding of MN-184 was significantly more frequent than MN-
30100, although virus concentrations in respiratory samples and nasal swabs did not differ 
(Cho et al., 2006, 2007).  Subsequently, Cho et al. (2006) reported successful aerosol 
transmission of MN184 (4 of 10 attempts), but not isolate MN-30100 (0 of 10 attempts) 
under experimental conditions in which inoculated and recipient pigs were connected by a 
1.3 meter duct.  Air samples from chambers housing pigs inoculated with MN-184 were 
positive for virus (3 of 5 samples) by quantitative RT-PCR, whereas no airborne virus was 
detected (0 of 5 samples) in air samples from chambers housing pigs inoculated with MN-
30100.  These results were in agreement with earlier work reporting failure to achieve 
aerosol transmission using PRRS virus isolate MN-30100 (Mortensen et al., 2002).  Based on 
these comparative studies, it has been postulated that the transmissibility of PRRS virus in 
aerosols differs among isolates (Cho et al., 2006, 2007; Murtaugh et al., 2002).   
 
Methods for quantitative evaluation of PRRS virus transmissibility have been described 
(Hermann et al., 2005; Hermann et al., 2009).  In brief, virus is aerosolized into a reservoir; 
animals respire a specific dose of airborne virus, and are then monitored to determine if the 
exposure resulted in infection.  Whether exposure to a specific dose of airborne virus 
produces infection is a probability function described by the dose-response relationship 
between the pathogen and the host.  The median infectious dose (ID50), the dose at which 
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50% of those exposed become infected, is useful summary statistic of the dose-response 
curve.  That is, ID50 is a measure of the infectivity of the specific pathogen that provides for 
the comparison infectivity among different pathogens and/or isolates.  Previously, the ID50 of 
airborne PRRS virus isolate VR-2332 was determined (Han et al., 2007).  The objective of 
this study was to estimate the ID50 of the PRRS virus isolate MN-184 via aerosol exposure 
and compare to the earlier ID50 estimate for isolate VR-2332. 
 
2.0  MATERIAL AND METHODS 
2.1  Institutional compliance 
The experiment and all procedures were approved by the Iowa State University Institutional 
Biosafety Committee (#07-I-029-A) and the Institutional Animal Care and Use Committee 
(#9-07-6429-S). Animals were housed and cared for in compliance with the requirements 
provided in the Guide for the Care and Use of Agricultural Animals in Agricultural Research 
and Teaching (Federation of Animal Science Societies 1999).   
 
2.2  Experimental design 
The study was conducted in 10 replicates, with pigs randomly assigned to exposure dose.  To 
conduct the experiment, 8 or 9 pigs per replicate were sequentially exposed to successively 
lower doses of airborne PRRS virus (Figure 1).  Decreasing aerosolized viral exposure 
concentrations were achieved by removing 190 liters of air between each pig.  Air samples 
collected before and after each pig were used to estimate the exposure dose.  Serum samples 
collected from each pig 5 and 10 days post-exposure (DPE) were tested for the presence of 
PRRS virus to determine whether exposure resulted in infection.  The dose-response curve 
for exposure to airborne PRRS virus was derived from the proportion of pigs infected by 
dose.  
 
In each replicate, one pig (negative control) was used to validate biosecurity procedures, i.e., 
was present in the laboratory during the aerosol exposure treatments, was housed in the same 
room as pigs exposed to PRRS virus aerosols, and was monitored throughout the observation 
period.  A second pig (positive control) was inoculated intramuscularly with 10 ml of fluid 
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from the final air sample in each run to verify that infectious PRRS virus was present in the 
air source to which pigs were exposed throughout the experiment.  Failure to detect 
infectious virus in the final air sample by bioassay invalidated the entire replicate. 
 
2.3  Animal care and housing 
Pigs were received at approximately 3 weeks of age from a PRRS virus-negative herd.  
Throughout the experiment, pigs were fed a commercial pelleted diet (Kent Feeds Inc., 
Muscatine, IA) that met or exceeded the age-appropriate nutritional requirements for swine 
set by the National Research Council, (1998).  To verify their PRRS virus-negative status, 
pigs were tested on -4 and 0 DPE for PRRS virus by virus isolation and anti-PRRS virus 
serum antibodies by ELISA (HerdChek® PRRS 2XR, IDEXX Laboratories, Inc., Portland, 
ME, USA).   
 
Animals were individually housed in hepa-filtered (Flanders Filters, Inc., Washington, NC, 
USA) isolation units (Barrier Systems, Inc., Toms River, NJ, USA).  Isolation units were 
equipped with air, feed, and waste handling systems that maintained a biosecure environment 
and prevented transmission of PRRS virus between pigs.  Between replicates, the isolation 
units were cleaned and disinfected with chlorhexidine diacetate (#Nolvasan1 Solution; Fort 
Dodge Laboratories, Fort Dodge, IA, USA) and then left empty for at least 48 h with the 
heating system set at 32°C and the hepa-filter air system in operation.   
 
2.4  Virus propagation 
A type 2 PRRS virus isolate, MN-184 (kindly provided by Dr. Scott Dee, University of 
Minnesota, MN, USA) was propagated on MARC-145 cells, a clone of the African monkey 
kidney cell line MA-104 (Kim et al., 1993).  Cells were grown in 162 cm2 flasks (Corning, 
Corning, NY, USA) using Dulbecco’s Modified Eagles Medium (DMEM) (Mediatech, Inc., 
Manassas, VA, USA) supplemented with 0.25 μg/ml Amphotericin B (Sigma Chemical Co., 
St. Louis, MO, USA), 50 μg/ml gentamicin (Sigma), 0.5 molar L-glutamine (Fisher 
Scientific, Hampton, NH, USA), 300 international units (IU) per ml penicillin (Sigma), 300 
μg/ml streptomycin (Sigma), 1.0% nonessential amino acids (HyClone, Logan, UT, USA), 
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25 mM HEPES buffer (Sigma), and 10.0% heat-inactivated fetal bovine serum (FBS) 
(Sigma, verified BVDV free).  When cells were confluent (72 to 84 hrs), the media was 
discarded and the flasks inoculated with 5 ml DMEM (without L-glutamine) containing 
PRRS virus isolate MN-184 at a titer of 1 x 103.5 median tissue culture infective dose 
(TCID50) per ml.  Flasks were placed on a rocking platform in a 37°C humidified 5% CO2 
incubator for 90 min, then 40 ml of modified DMEM growth medium with 4% FBS was 
added and the flasks returned to the incubator for 36 hrs.  Cell culture supernatant was 
harvested by flask freeze-thaw and centrifugation (3000 x g for 20 min at 4°C).  Virus stock 
was stored in 25 ml aliquots at -80°C.  
 
2.5  Microinfectivity assays 
Samples to be quantified for PRRS virus were serially 10-fold diluted (10-0 to 10-5) in 
DMEM growth medium without FBS and assayed in triplicate on confluent MARC-145 cells 
propagated in 96-well tissue culture plates (Corning).  Growth medium was discarded from 
plates, 5 wells were inoculated with 100 μl of sample at each dilution, and the plates placed 
in a 37°C humidified 5% CO2 incubator for 90 min.  The inoculum was then discarded, 100 
μl per well of growth medium containing 4% FBS was added to each well, and the plates 
incubated at 37°C in a humidified 5% CO2 incubator for 24 hrs.  Following incubation, cells 
were fixed with cold 80% acetone/water solution and stained with a fluorescein 
isothiocyanate-conjugated (FITC) monoclonal antibody specific for PRRS virus (Rural 
Technologies Inc., Brookings, SD, USA).  Virus titers (TCID50 per ml) and 95% confidence 
intervals were calculated based on the number of wells showing PRRS virus-specific 
fluorescence at each dilution using Spearman-Kärber and logit methods (Spouge, 1991).   
 
2.6  Virus aerosolization, air sampling, and sample handling 
Airborne PRRS virus for pig exposure was provided by nebulizing PRRS virus into a 400 
liter stainless steel dynamic aerosol torrid (DAT) rotating at 4 RPM (Brother International 
Gearmotors, Bridgewater, NJ, USA).  Virus infectivity was maintained by housing the entire 
apparatus within a custom-built refrigeration unit held at -4˚C (Carroll Coolers, Inc., Carroll, 
IA, USA).  To allow for pressure equilibration during nebulization, impingement, and pig 
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exposure, three HEPA-filters (Fisher Scientific, Hampton, NH, USA) were fixed to ports on 
the circumference of the DAT.  The entire system was disassembled, cleaned, and disinfected 
between replicates.   
For each replicate, a solution consisting of virus stock (1 x 107.7 TCID50 per ml), 0.08% v/v 
rhodamine B dye (Sigma Chemical Co.), and 0.1% v/v Antifoam A Emulsion (Sigma 
Chemical Co.) was aerosolized into the DAT using a 24-jet Collison nebulizer (BGI Inc., 
Waltham, MA, USA), operating at 40 PSI.  According to the manufacturer, the solution was 
aerosolized at a rate of 1.1 ml per minute and produced particles 1.9 μm in diameter.  The 
aerosol was allowed to mix and stabilize within the DAT for 60 minutes after nebulization.   
 
Air samples were collected from the DAT over the course of each replicate to monitor the 
concentration of airborne PRRS virus and rhodamine B, i.e., 200 liter air samples (n = 4) 
were collected following the stabilization period and 190 liter samples were collected 
following each pig exposure.  Air samples were collected using 20 ml of sterile 1X PBS in 
sterile AGI-30 glass impingers, (Ace Glass, Vineland, NJ, USA), operated at a constant flow 
rate of 12.5 liter per minute.  Impinger collection bottles were placed on ice during the 
collection process to maintain virus viability.  Following collection, bottles were maintained 
on ice for transport to the laboratory.  Sample collection fluid was assayed for the 
concentration of PRRS virus (described above) and rhodamine B dye.  Virus microinfectivity 
assays were performed immediately post sample collection, the concentration of rhodamine 
B dye was quantified using a fluorometer (Model - 9200-000, Turner BioSystems Inc., 
Sunnyvale, CA, USA) equipped with a green optical kit (Model - 9200-042, Turner 
BioSystems Inc.) and expressed as raw fluorescence units.  Fluorometer performance was 
verified prior to each replicate using a rhodamine B solid standard (Turner BioSystems Inc.). 
 
2.7  Animal exposure to virus aerosol 
Pigs were removed from individual isolation units on day 0, bled, and anesthetized using a 
solution formulated by reconstituting Telazol (250 mg of tiletamine, 250 mg of zolazepam; 
Fort Dodge Animal Health, Fort Dodge, IA, USA) with 2.5 ml of xylazine (100 mg/ml; 
Lloyd Laboratories, Shenandoah, IA, USA) and 2.5 ml of ketamine (100 mg/ml; Fort Dodge 
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Animal Health).  The solution was administered intravenously at a dose of 0.025 ml per kg of 
body weight. 
 
For exposure to the virus aerosol, the entire anterior portion of the head, i.e., snout and 
mouth, of the anesthetized pig was fitted with a canine surgical mask (Model - 32393B1, 
SurgiVet, Waukasha, WI, USA).  To prevent rebreathing of respired aerosol, a one-way 
valve (Model - BE-117, Instrumentation Industries, Inc., Bethel Park, PA, USA) was 
attached to the tubing inserted into the DAT containing aerosolized infectious PRRS virus.  
Each pig respired 10 liters of PRRS virus aerosol.  The exposure time was recorded and the 
cumulative volume (liters) of air respired by the animal during the exposure period was 
measured using a pediatric spirometer (Model 8805, Boehringer Laboratories Inc., 
Norristown, PA, USA).  The one-way valve, tubing and mask were replaced between animals 
(Figure 1).   
 
2.8  Determination of infection status post-exposure 
Serum samples were collected using a single-use blood collection system (Becton Dickinson, 
Franklin Lakes, NJ, USA).  Blood samples were centrifuged at 3000 x g for 10 min, after 
which the serum was harvested and stored at -80˚C.  Samples were collected on DPE -4, 0, 5, 
and 10.  Samples were tested for anti-PRRS virus antibodies using a commercial PRRS 
ELISA (IDEXX HerdChek® PRRS 2XR, IDEXX Laboratories, Westbrook, ME, USA) and 
by virus isolation.  Virus isolation on serum samples was performed as described above by 
inoculating wells of a 96-well plate with undiluted serum.  A positive result was indicated by 
a PRRS virus-specific fluorescence reaction.   
 
2.9  Analysis 
2.9.1  Determination of PRRS virus aerosol exposure dose 
Determination of aerosol exposure dose required precise information on the concentration of 
airborne PRRS virus within the DAT.  Impinger fluid concentration of PRRS virus (TCID50) 
in the first DAT aerosol sample was used to determine the initial virus (per liter) 
concentration of aerosol:   
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(1) ࢀࢇ ൌ ሺࢀ࢕  ൈ  ࢂࢌሻ /ࡸ࢏  
Where : 
 ࢀࢇ  = PRRS virus TCID50 per liter of air within the DAT 
 ࢀ࢕  = PRRS virus TCID50 per ml of impinger fluid 
 ࢂࢌ  = Total volume of impinger fluid in milliters 
 ࡸ࢏  = Liters of air impinged (sampled) 
 
The concentration of PRRS virus in subsequent impinger samples was below the threshold of 
quantification by the microinfectivity assay.  Therefore, two indirect methods were used to 
establish virus concentration per liter of air. For both methods, a key point is that the DAT 
was maintained below freezing (-4°C).  That is, the indirect methods were valid because the 
frozen virus did not lose infectivity over the course of the exposure sequence.   
 
2.9.1.1  Calculated virus concentration 
Hermann et al. (2007) reported no statistically significant difference (p = 0.99) in the slopes 
of rhodamine B and PRRS virus RNA concentrations in a study conducted in the DAT 
environment.  These results affirmed that the slope of rhodamine B could be used to calculate 
airborne PRRS virus concentration within the DAT over the course of the experiment.  
Results based on this approach are hereafter referred to as "calculated" estimates.   
 
2.9.1.2  Theoretical virus concentration 
The second indirect method was based on the continuous stirred-tank reactor model (CSTR).  
Validation of this model in context of aerosols contained with a DAT is reported elsewhere 
(Cutler et al., 2010).  In brief, a CSTR is a vessel characterized by steady-state and uniform 
internal conditions due to mixing (Hill, 1977).  The application of this model to this 
experiment results in the following relationships:   
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 (2)  ࡯࢘࢏  ൌ ࡯࢘࢕  ൈ  ࢋሺࢂ࢚࢘/ࢂ࢚ሻ    
Where: 
 ࡯࢘࢏  = Virus or rhodamine B concentration per liter of air for Time (t) 
 ࡯࢘࢕ = Virus or rhodamine B concentration at Time 0 
 ࢂ࢚࢘ = Cumulative volume of air removed from the DAT 
 ࢂ࢚  = Total volume of the DAT (400 liters) 
  e    = Base of natural logarithm (Euler’s number)  
 
Log transformation of equation 2 results in a linear response that allowed for the prediction 
of virus or rhodamine B concentration:  
 
 (3) ࢒࢕ࢍ૚૙࡯࢘࢏ ൌ ࢒࢕ࢍ૚૙࡯࢘࢕ െ ሺ࢒࢕ࢍ૚૙ሺࢋ/ࢂ࢚ሻሻ  ൈ ࢂ࢚࢘ 
 
Equation 3 described a linear relationship between the concentration of an airborne target and 
the volume of air removed from the DAT in which the concentration of the target is a 
function of the slope െሺ࢒࢕ࢍ૚૙ሺࢋ/ ࢂ࢚ሻሻ.  Therefore, the level of the target (PRRS virus or 
rhodamine B) could be estimated for any time ሺ࡯࢘࢏ሻ during the sampling sequence based on 
the initial virus concentration.  Results based on this approach are hereafter referred to as 
"theoretical" estimates.   
 
2.9.1.3  Pig virus aerosol exposure dose 
The PRRS virus aerosol exposure dose for each animal was determined by multiplying the 
airborne PRRS virus concentration per liter of air at the specific exposure point by the 
number of liters the pig respired (10 liters).  Two virus concentration estimates ("calculated" 
and "theoretical") were derived and used in the analysis.   
 
2.9.2  Dose-response: Probability of infection by exposure dose  
Each pig was considered an experimental unit because animals were treated individually and 
housed individually in HEPA-filtered units.  The outcome was defined as a binary variable, 
i.e., aerosol exposure to a specific dose of PPRSV either produced infection or did not.  
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Among the 58 pigs exposed to aerosolized PRRS virus 34 pigs became infected. 
 
The probability of infection after aerosol exposure was modeled on the proportion of pigs 
that became infected by dose.  The generalized linear regression models (logit and probit link 
functions) were used to fit the binary response (infection) with the explanatory variable 
(exposure dose) using the PROBIT procedure of SAS® Version 9.1.3 Service Pack 4 of the 
SAS® System for Windows (SAS® Institute Inc., Cary, NC, USA).  The logit model was 
represented as ln [P/(1-P)], where P represents the probability that an individual chosen at 
random will become infected by a given dose “x”.  P may be obtained from the logistic 
function:  
 
 (4) P = [1 + exp(-α – βx)]-1, –∞ < x < ∞   
 
Logit P was estimated from the linear functions logit P = α + βx (Govindarajulu, 2001).   
 
In the probit model, P was obtained from the cumulative distribution function of the standard 
normal distribution (Ф): 
 
 (5)  Pൌ ሺ2ߨሻିభమ ׬ ݁ݔ݌ఈାఉି∞ ቀെ ௨
మ
ଶ ቁ ݀ݑ, െ∞ ൏ ݔ ൏ ∞ 
 
Subsequently, probit P was estimated form the function probit P = normal deviate = ߙ ൅ ߚݔ 
(Govindarajulu, 2001).   
 
The median infective dose (ID50) point estimate and 95% confidence intervals were estimated 
for each model and for both calculated and theoretical PRRS virus concentrations.  The ID50 
estimates were expressed as TCID50, i.e., the quantity of virus necessary to infect 50% of the 
pigs exposed to aerosolized PRRS virus isolate MN-184.   
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3.0  RESULTS 
Serum samples from pigs collected on -4 and 0 DPE were negative for anti-PRRS virus 
antibodies using a commercial PRRS ELISA and by virus isolation indicating that animals 
had not had prior exposure to PRRS virus.  Each replicate consisted of 8 or 9 pigs exposed to 
PRRS virus aerosol, one negative control pig, and one positive control pig.  Among all pigs, 
the mean body weight on DPE 0 was 12.8 kg (range 10.2 to 17.5 kg).  Among aerosol-
exposed pigs, 10 liters of PRRS virus aerosol was respired in a mean time of 5 min 6 sec 
(range 2 min 21 sec to 7 min 42 sec).  Following exposure, no mortality occurred during the 
monitoring period and it was not possible to determine whether pigs had become infected 
with PRRS virus on the basis of gross appearance. That is, no overt clinical signs were 
observed.   
 
Of the 10 replicates, data from 3 replicates were excluded from the analysis.  (1) One 
replicate was voided because the negative control became infected with PRRS virus, 
indicating a breach in protocol.  (2) One replicate was voided because the positive control did 
not become infected, indicating that viable PRRS virus was not present throughout the 
exposure sequence.  (3) One replicate was voided due to mechanical failure during the 
replicate resulting in improper air sampling.  Thus, the statistical analysis was based on 7 
successful replicates in which 34 of 58 (59%) pigs became infected by exposure to airborne 
PRRS virus.   
 
Impinger fluid concentration of PRRS virus (TCID50) in the first DAT aerosol sample ranged 
from 1 x 101.1 (95% CI:  100.8, 101.4) to 1 x 103.6 (95% CI:  103.2, 104.1) TCID50 per ml.  All 
subsequent analysis were based on these estimates.  "Theoretical" and "calculated" ID50 
estimates derived for probit and logit models are given in Table 1 and shown in Figure 2.   
 
4.0  DISCUSSION  
Porcine reproductive and respiratory syndrome virus has long been recognized as highly 
infectious, i.e., Yoon et al. (1999) found that less than 1 x 101 TCID50 was sufficient to infect 
pigs via intramuscular exposure with PRRSV virus isolate ISU-P.  The purpose of present 
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study was to quantify the infectivity of a PRRS virus isolate administered to pigs via aerosol 
exposure by calculating the median infectious dose (ID50).  ID50, the dose necessary to infect 
50% of the exposed population, is derived from the dose-response curve describing the 
relationship between the level of exposure to a microorganism (dose), and the probability that 
the exposure will result in infection (response).  For the same agent, the ID50 may vary by the 
route of exposure, e.g., the ID50 via oral exposure for PRRS virus isolate VR-2332 was 
estimated at 1 x 105.3 TCID50 versus 1 x 104.0 TCID50 for intranasal exposure (Hermann et al., 
2005).  As well, ID50s may vary among isolates from the same species, e.g., Sellers and 
Gloster (2007) reported that infectivity differed both between foot-and-mouth disease virus 
(FMDV) types (O, A, C) and among isolates within types. 
 
In the present study, the most conservative ID50 estimate for aerosol exposure to isolate MN-
184 was 1 x 100.26 TCID50 (Table 1), with the 95% confidence intervals encompassing the 
other 3 point estimates.  In contrast, Hermann et al. (2009), reported an ID50 of 1 x 103.1 
TCID50 by aerosol exposure using isolate VR-2332.  Both estimates were produced by the 
same laboratory working with pigs of approximately the same age and using the same 
experimental design, equipment, and protocols.  For this reason, it may be concluded that 
both estimates are valid and the divergent estimates represent a true difference between the 
two PRRS virus isolates.  Overall, the results raise the possibility of a distribution of ID50s 
for the airborne route among PRRS virus isolates, a distribution for which we have only two 
ID50 point estimates.   
 
Early in the PRRS virus pandemic, the pattern of transmission was highly suggestive of 
airborne transmission (Goyal, 1993; Le Potier et al., 1997).  This impression was 
strengthened by epidemiological studies suggesting that PRRS virus could be transmitted 
over distances of 1.25 m (Wills et al., 1997), 0.5 km (Le Potier et al., 1997), and up to 3 km 
(Mortensen et al., 2002).  However, experimental work produced inconsistent reproduction 
of airborne transmission.  For example, Torremorell et al. (1997) demonstrated transmission 
of PRRS virus isolate VR-2332 over a distance of one meter in one of 2 attempts, but were 
unable to detect PRRS virus in 125 liter air samples collected on each of 3 days.  Otake et al. 
56 
(2002) reported transmission of PRRS virus isolate MN-30100 over a distance of 2.5 meters 
from infected animals to susceptible pigs sharing the same air space, but aerosols emitted 
from exhaust fans over distances of one to 30 meters did not transmit PRRS virus to sentinel 
pigs.  The first exception to this pattern of poor aerosol transmissibility was a report of 
airborne transmission of PRRSV–EU across a distance of one meter distance in each of 3 
attempts (Kristensen et al., 2004).  The most comprehensive research on aerosol transmission 
has been done with PRRS virus isolate MN-184.  Cho et al. (2007) reported that, in contrast 
to isolate MN-30100, only isolate MN-184 produced successful transmission to susceptible 
pigs and only MN-184 was detected in air samples.  Using MN-184 infected animals as the 
source, Dee et al. (2010) successfully infected 14 of 26 replicates (10 pigs per replicate) at a 
distance of 120 meters.   
 
Particularly under experimental conditions in which host infection and immune status can be 
established with certainty, it may be assumed differences in infectivity are primarily driven 
by viral genetics.  As reviewed by Murtaugh et al. (2010), on-going genetic evolution of 
PRRS viruses is the result of mutation resulting from RNA polymerase infidelity and 
genomic recombination.  It may be speculated that differences in infectivity among PRRS 
viruses result from genetic changes that reflect greater adaptation of the virus to its porcine 
host.  Such adaptation has been shown to occur in other viruses.  For example, Fry et al. 
(2005) reported that FMDV acquired the capacity to bind to heparin sulphate receptors under 
selection pressure in cell culture, rather than the targeted integrin receptors.  PRRS virus 
isolate VR-2332, the only other isolate for which we have an ID50 estimate for aerosol 
exposure, was recovered in 1990 during the height of the North American PRRS virus 
epidemic and perhaps no more than 5 years after the virus was introduced in the continent 
(Benfield et al., 1992; Zimmerman et al., 1997).  In contrast, isolate MN-184 was isolated in 
2001 (Johnson et al., 2004).  This additional decade of replication in pigs may have provided 
for further adaptation to the virus' porcine host that is reflected in its greater infectivity.   
 
Data critical to interpreting the results of this study are missing.  Specifically, it is not known 
whether the greater infectivity demonstrated for MN-184 by aerosol exposure is also 
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reflected in greater infectivity by oral, intranasal, or percutaneous exposures.  Likewise, in 
terms of understanding the mechanisms underlying these biological differences, the paucity 
of ID50 estimates for PRRS viruses precludes hypothesis testing.   
  
5.0  CONCLUSION 
The present work describes a standardized protocol for determining the ID50 for viruses in 
aerosols.  This methodology provided the basis for demonstrating differences among PRRS 
virus isolates in ID50 by aerosol exposure.  Questions remain to be answer regarding the 
range, distribution, and genetic basis of such differences.  Likewise, the relationship between 
ID50s by aerosol, oral, percutaneous, and intranasal exposures and the factors that drive virus 
infectivity remain to be established.  Logically, modified live vaccine viruses should be 
evaluated and screened for infectivity in order to select for vaccines with a reduced potential 
for unintended transmission. 
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TABLES AND FIGURES 
 
 
Figure 1. Diagram of the experimental procedure for exposing pigs to aerosolized 
porcine reproductive and respiratory syndrome (PRRS) virus (From 
Hermann, et al., 2009 by permission of the publisher) 
  1.  Modified refrigerator-freezer unit maintained at -4°C 
 2.  Dynamic aerosol toroid (DAT) for holding virus aerosol in suspension  
  A.  Port for connection to DAT 
  B.  Collision nebulizer for generating PRRS virus aerosol   
  C.  Pediatric spirometer for measuring cumulative respired volume    
  D.  Hepa-filtered exhaust 
  E.  Canine anesthesia mask  
  F.  Impinger for collecting air samples 
3.  Temperature and DAT rotation controls 
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Figure 2.  Probit and logit median infectious dose (ID50) estimates of aerosolized infectious PRRS virus.  [A = Probit ID50 
based on "theoretical" virus concentration;  B = Probit ID50 based on "calculated" virus concentration;  C = Logit 
ID50 based on theoretical virus concentrations;  D = Logit ID50 based on calculated virus concentration] 
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Table 1.   Median infectious dose (ID50) point estimates and 95% confidence intervals 
expressed as median tissue culture infectious dose (TCID50) 
 
Probability 
function Exposure dose ID50
* ID50 95% confidence interval 
Probit Theoretical 1 x 100.26 1 x 10-0.96, 1.09 
 Calculated 1 x 10-0.13 1 x 10-1.16, 0.63 
Logit Theoretical 1 x 100.24 1 x 10-0.94, 1.10 
 Calculated 1 x 10-0.14 1 x 10-1.19, 0.67 
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CHAPTER 4.  KINETICS OF ULTRAVIOLET (UV254) INACTIVATION OF 
SELECTED VIRAL PATHOGENS IN A STATIC SYSTEM 
 
T. Cutler, C. Wang, Q. Qin, F. Zhou, K. Warren, K.-J. Yoon, 
S.J. Hoff, J. Ridpath, J. Zimmerman 
 
A paper submitted to the Journal of Applied Microbiology 
 
ABSTRACT 
Aims:   The objective of this study was to estimate UV254 inactivation constants for four viral 
pathogens:  influenza A virus, porcine respiratory and reproductive syndrome virus 
(PRRSV), bovine virus diarrhea virus (BVDV), and reovirus.   
Methods and Results:  Viruses in culture medium were exposed to one of 9 doses of UV254 
and then titrated for infectious virus.  Analysis showed that virus inactivation by UV254 was 
more accurately described by a two-stage inactivation model versus a standard one-stage 
inactivation model.   
Conclusions:  The results provided evidence for the existence of two heterogeneous virus 
subpopulations among the viruses tested, one highly susceptible to UV254 inactivation and the 
other more resistant.  Importantly, inactivation constants based on the one-stage inactivation 
model would have underestimated the UV254 dose required for inactivation of these viruses 
under the conditions of the experiment.   
Significance and Impact:  To improve the accuracy of estimates, it is recommended that 
research involving inactivation of microorganisms evaluate inactivation kinetics using both 
one-stage and two-stage models.  These results will be of interest to persons responsible for 
microbial agents under laboratory or field conditions. 
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INTRODUCTION 
Ultraviolet (UV) radiation is the part of the electromagnetic spectrum that lays between the 
high energy X-rays (≤ 100 nm) and the visible spectrum (> 400 nm).  UV254 inactivation has 
been a proven method of disinfection since the 1930s (Brickner et al. 2003).  In the 1960s, it 
was shown that inactivation of microbes occurred through dimer formation by nucleic acids, 
with 260nm determined to be the UV wavelength most efficiently absorbed by genetic 
material (Kowalski et al. 2001).   
 
The efficacy of ultraviolet inactivation is dependent upon several factors, including the 
microbe’s susceptibility to UV254.  Microbial susceptibility to UV254, generally termed the 
inactivation constant (k), is frequently modeled using the following: 
 
 (1) ܓ ൌ ܔܗ܏૚૙ቀ
N౪
N౥ቁ
۲ܗܛ܍  
Where: 
 k  = the inactivation constant 
 N0  = quantity of microbes at time zero 
 Nt  = quantity of microbes at UV254 exposure time "t"  
 Doset  = depth (centimeters) of the solution irradiated by UV254  
 
Thus, the one-stage inactivation model (Equation 1) describes the one-hit model which, when 
log10 transformed, is described by a linear relationship between the survival fraction of the 
microbial population and the UV254 exposure dose (Goldberg et al. 1958)  This model long 
served as the primary method for describing microbial susceptibility to UV254.  In 1964, Hiatt 
described the limitations of the model and proposed several alternate computational models 
to describe the inactivation of microbes (Hiatt 1964).  More recently Kowalski et al. (2001) 
described a two-stage inactivation model for UV254 inactivation of viruses.  The objective of 
the present study was to compare the one-stage and two-stage inactivation models and report 
the inactivation constants for two enveloped, (+)ssRNA viruses (porcine respiratory and 
reproductive syndrome virus, and bovine virus diarrhea virus), an enveloped (-)ssRNA virus 
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(influenza virus type A), and a non-enveloped dsRNA virus (reovirus) in a static 
environment.  The viruses chosen include economically significant animal pathogens for 
which estimates of UV254 inactivation are not available.   
 
MATERIALS AND METHODS 
Experimental design 
Viruses were suspended in culture medium and exposed to specific doses of UV254 by 
placing aliquots into wells of a modified 8-well plate (VWR, West Chester, PA, USA).  Each 
plate included a positive control virus (BVDV, PRRSV, reovirus, or influenza) which was 
protected from UV254 exposure by covering the well with aluminum foil.  To reduce bias, the 
placement of each virus within the plate, the unexposed virus control for each plate, and the 
UV254 dose for each plate was randomized.  Following UV254 exposure, the samples were 
harvested and stored at -80°C until titrated for infectious virus.  Virus inactivation data were 
analyzed using both the one-stage inactivation and two-stage inactivation models (Goldberg 
et al. 1958; Kowalski et al. 2001).       
 
Selected viruses 
Influenza virus          Influenza A/Swine/Iowa/73 (H1N1) (USDA: National Veterinary 
Service Laboratories, Ames, IA, USA) was propagated on Madin-Darby canine kidney 
(MDCK) cells (American Type Culture Collection (ATCC), Manassas, VA, USA).  Cells 
were grown in 162 cm2 flasks (Corning, Corning, NY, USA) using Dulbecco’s Modified 
Eagles Medium (DMEM) (Mediatech Inc., Manassas, VA, USA) supplemented with  0.25 μg 
ml-1 Amphotericin B (Sigma Chemical Co., St. Louis, MO, USA), 50 μg ml-1 gentomycin 
(Sigma Chemical Co.), 0.5 molar L-glutamine (Gibco, Carlsbad, CA, USA), 300 
international units (IU) ml-1 penicillin (Sigma Chemical Co.), 300 μg ml-1 streptomycin 
(Sigma Chemical Co.), 1.0% nonessential amino acids (HyClone, Logan, Utah, USA), 25 
mmol L-1 HEPES buffer (Sigma Chemical Co.), and 10.0% heat-inactivated fetal bovine 
serum (FBS) (Sigma Chemical Co., verified BVDV free).  When cells were confluent, the 
media was discarded and the flasks rinsed with 15 ml of complete infecting medium (CIM): 
500 ml DMEM growth medium, 7.8% bovine serum albumin (BSA) (Sigma Chemical Co.) 
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in place of 10% FBS, and 0.83 ml of trypsin working stock.  Trypsin working stock was 
formulated at 100 mg of L-(tosylamido-2-phenyl) ethyl chloromethylketone (TPCK-treated) 
trypsin (Worthington Biochemical, Lakewood, NJ, USA) diluted into 100 ml of CIM.  Flasks 
were inoculated with 5 ml of CIM containing influenza virus at a titer of 1.26×106 TCID50 
ml-1 and placed on a rocking platform in a 37°C humidified 5% CO2 incubator for 90 min, 
after which the inoculate was discarded and replaced with 50 ml of maintenance medium 
(MM): DMEM growth medium with 4% heat-inactivated FBS in place of 10% FBS.  Flasks 
were incubated at 37°C in a humidified 5% CO2 incubator and cells examined daily for 
cytopathic effect (CPE).  When ≥75% CPE was observed, flasks were freeze-thawed and the 
cell lysate harvested.  The harvested lysate was centrifuged at 10,000 x g for 20 minutes at 
4°C, decanted, and the supernatant stored at -80°C. 
 
Porcine reproductive and respiratory syndrome virus          A type 2 PRRSV isolate MN-
184 (provided by Dr. Scott Dee, University of Minnesota) was propagated in MARC-145 
cells (Iowa State University, Veterinary Diagnostic Laboratory, Ames, IA, USA), confluent 
cells were inoculated with 5ml of MN-184 virus at a titer of 1 x 103.5 TCID50 ml-1.  The flasks 
were placed on a rocking platform in a 37°C humidified 5% CO2 incubator for 90 min, then 
40 ml of DMEM growth medium with 4% heat-inactivated FBS in place of 10% FBS, was 
added and the flasks returned to the incubator for 36 hrs.  Cell culture supernatant was 
harvested by flask freeze-thaw and centrifugation (10,000 x g for 20 minutes at 4°C).  Virus 
stock was stored in 25 ml aliquots at -80°C.  
 
Bovine viral diarrhea virus          Singer strain bovine viral diarrhea virus (BVDV) type 2 
(provided by Dr. J. Ridpath, USDA: NADC) was propagated on bovine turbinate cell line T7 
(provided by Dr. J. Ridpath, USDA: NADC).  The cells were grown in 162 cm2 flasks using 
EME growth medium: EME medium (Sigma Chemical Co.) containing 0.25 μg ml-1 
Amphotericin B (Sigma Chemical Co.), 50 μg ml-1 gentomycin (Sigma Chemical Co.), 300 
IU ml-1 penicillin (Sigma Chemical Co.), 300 μg ml-1 streptomycin (Sigma Chemical Co.), 
and supplemented with 10% FBS (Sigma Chemical Co., verified BVDV free).  When cells 
were 75% confluent, the media was discarded and the flasks inoculated with 5 ml EME 
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growth medium containing BVDV at a titer of 1.26 × 106 TCID50  ml-1 and placed on a 
rocking platform in a 37°C humidified 5% CO2 incubator for 90 min.  Thereafter, 40 ml of 
EME growth medium was added and the cells examined daily for cytopathic effect (CPE).  
When approximately 75% CPE was observed, cell culture supernatant was harvested by flask 
freeze-thaw and centrifugation (10,000 x g for 20 minutes at 4°C).  Virus stock was stored in 
25 ml aliquots at -80°C. 
 
Reovirus          Reovirus strain T3DC (provided by Dr. Cathy Miller, Iowa State University) 
was propagated in spinner culture-adapted murine fibroblasts (L929 cells) as described in 
Qin et al. (2009).  Confluent L929 cells were incubated with a multiplicity of infection of 10 
plaque forming units per cell in Joklik c-MEM (Sigma Chemical Co.) and stirred for 3 days 
at 35ºC.  Thereafter, the cells were pelleted, the supernatant discarded, and the pellet re-
suspended in an equal volume of fresh media.  The re-suspended cells were sonicated, as 
described by Nibert and Fields (1992), and then centrifuged at 3000 x g for 5 min.  The 
supernatant was adjusted to a virus concentration of 1.7 x 109 PFU ml-1 with Joklik c-MEM 
media and stored at 4°C until used. 
 
Virus titration 
Samples were assayed for infectious virus following the procedures described below.  To 
avoid bias, sample aliquots were assayed blind and in random order.  Virus titers were 
calculated using the Spearman-Kärber method and expressed as the median tissue culture 
infective dose (TCID50) ml-1 (Huber 1992).  
 
Influenza virus microinfectivity and hemagglutination assays          Swine testicle (ST) 
cells (ATCC CRL-1746) were propagated in 96-well tissue culture plates (Costar, Corning, 
NY, USA) using MEM growth medium: (MEM) minimum essential medium eagle (Sigma 
Chemical Co.) containing 0.25 μg ml-1 Amphotericin B (Sigma Chemical Co.) 50 μg ml-1 
gentomycin (Sigma Chemical Co.), 2mmol L-1 L-glutamine (Sigma Chemical Co.), 100 IU 
ml-1 penicillin (Sigma Chemical Co.), 100 μg ml-1 streptomycin (Sigma Chemical Co.), and 
supplemented with 10% heat inactivated fetal bovine serum (Atlas, Fort Collins, CO, USA).  
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Duplicate, samples were serially 10-fold diluted (10-1 to 10-6) in MEM growth medium with 
2% heat-inactivated FBS in place of 10% FBS.  Test and control sample serial dilutions were 
plated at 100 µl per well onto confluent cells.  Plates were incubated in a 37°C humidified 
5% CO2 incubator and observed daily, when ≥50% CPE was observed, or at the end of the 7 
day incubation, the plates were frozen at -80°C.   
 
All samples were also tested using a hemagglutination (HA) assay.  In brief, 50 μl of positive 
control (Influenza A/Swine/Iowa/73 (H1N1), negative control (1X PBS, pH = 7.2), and fluid 
from freeze/thawed CPE-positive wells was added to an untreated 96-well round bottom 
microtitration plate (Evergreen Scientific, Los Angeles, CA, USA) and serially 2-fold diluted 
(1:2 to 1:256) in 1X PBS.  Thereafter, 50 μl of 0.55% turkey red blood cells (USDA: NVSL) 
was added to each well and the plates incubated for 30 min at 25°C.  A positive reaction 
produced red blood cell agglutination, i.e., a “mat” at the bottom of the well.   
 
Samples demonstrating CPE on the microinfectivity assay and an HA virus titer ≥1:4 were 
considered positive for infectious influenza virus.  Virus titers were calculated on the basis of 
the number of wells in the microinfectivity assay showing CPE.  Each sample was run in 
duplicate with the titers averaged. 
 
Porcine reproductive and respiratory syndrome virus microinfectivity assay          
MARC-145 cells propagated in 96-well tissue culture plates (Corning) using DMEM growth 
medium were incubated at 37°C in a humidified 5% CO2 incubator for 72 hr.  Samples to be 
assayed were serially 10-fold diluted (10-1 to 10-5) in DMEM growth medium without FBS.  
The growth medium was discarded and 5 wells were inoculated with 100 μl of sample at 
each dilution.  The plates were placed in a 37°C humidified 5% CO2 incubator for 90 min, 
the inoculum was discarded, and 100 μl per well of growth medium containing 4% FBS, 
rather than 10% FBS was added to each well.  Plates were incubated at 37°C in a humidified 
5% CO2 incubator for 24 hrs.  Following incubation, cells were fixed with cold, 80% 
acetone/water solution and stained for 30 min at 37°C with SDOW-17F, fluorescein 
isothiocyanate-conjugated monoclonal antibody specific for PRRSV diluted according to 
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manufacturer's instructions (Rural Technologies Inc., Brookings, SD, USA).  Virus titers 
were calculated on the basis of the number of wells showing a PRRSV-specific fluorescence 
reaction at each dilution.  Each sample was run in triplicate and the titers averaged.  
 
Bovine viral diarrhea virus microinfectivity assay          Madin-Darby Bovine Kidney cells 
(MDBK), (ATCC) were propagated in 96-well plates (Costar) using complete Ex-Cell™ 
MDBK-MM Medium (Sigma Chemical Co.) containing 0.25 μg ml-1 Amphotericin B (Sigma 
Chemical Co.), 50 μg ml-1 gentomycin (Sigma Chemical Co.), 2mmol L-1 L-glutamine 
(Sigma Chemical Co.), 100 IU ml-1 penicillin (Sigma Chemical Co.), 100 μg ml-1 
streptomycin (Sigma Chemical Co.) and supplemented with 5% heat-inactivated equine 
serum (HyClone).  Plates were incubated at 37°C in a humidified 5% CO2 incubator until the 
cell monolayer was confluent.  Samples were serially 10-fold diluted (10-1 to 10-6) in 
complete Ex-Cell™ MDBK-MM Medium and 100 µl per well of each sample dilution was 
applied over the cell suspension.  Plates then incubated at 37°C in a humidified 5% CO2 
incubator for 24 hr, then the growth medium was replaced with 200 µl per well of complete 
medium.  The plates were returned to the incubator for an additional 24 hr and viewed for 
CPE.  The plates were then frozen at -80°C until confirmatory testing to be carried out.  
Confirmatory testing and genotyping of BVDV results was done using RT-PCR with 
visualization on a 2% agarose-gel (Ameresco, Solon, OH, USA).  The viral RNA was 
extracted as per the manufacturer’s specifications using the Ambion MagMAX™-96 Viral 
RNA Isolation Kit (Ambion, Austin, TX, USA); reverse transcribed and amplified using the 
Qiagen® One-Step RT-PCR Kit (Qiagen, Valencia, CA, USA).  Thermal cycling conditions 
were as follows; 50°C for 30 minutes, melt at 95°C for 15 minutes, 35 cycles of 
amplification at 94°C for 30 seconds, 50°C for 30 seconds, 72°C for 1 minute, and extension 
for 10 minutes at 72°C.  Primers used were 5’-TCGACGCCTTRRCATGAAGGT-3’ and 5’-
TCGACGCTTTGGAGGACAAGC-3’.  The 180 basepair product was run on a 2% agarose 
gel and visualized under UV illumination.  
 
Reovirus plaque assay          L929 cells in Joklik’s minimum essential medium (Sigma 
Chemical Co.) containing 10% fetal bovine serum (Atlanta Biological, Lawrenceville, GA, 
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USA) were added to 6-well plates (Corning) at a concentration of 2  106 cells per well and 
incubated at 37°C overnight.  Thereafter, the medium was removed and the cells were 
washed once with sterile 1X PBS.  To conduct the assay, the sample was serially diluted ten-
fold, 100 μl per well was added and allowed to adsorb for one hr at 25°C.  The wells were 
then overlaid with 2 ml of complete 1X Medium 199 at 37°C.  Overlay was formulated as 2X 
Medium 199 (Sigma Chemical Co.) containing 4 mmol L-1 ml-1 L-Glutamine (Mediatech), 
200 IU  ml-1 penicillin, 200 µg ml-1 streptomycin (Mediatech), and 20 µg ml-1 trypsin 
(Mediatech) to which was added to an equal volume of 58°C 2% agar (BD Bacto™, Franklin 
Lakes, NJ, USA).  The plates were incubated for 48 h in a 37°C humidified 5% CO2 
incubator prior to counting plaques.   
 
Exposure of viruses to ultraviolet (UV254)  
Source of ultraviolet          The UV254 emitting apparatus consisted of an 18 inch (46 cm), 2-
lamp, surface-mounted, 110 volt, Ultraviolet fixture (American UV Company, Lebanon, IN, 
USA) fitted with two standard output, quasi-colliminated beam, low pressure, mercury vapor 
germicidal lamps emitting monochromatic ultraviolet radiation at 253.7 nm (American UV 
Company).  For uniform output, the lamps were "burned in" for 8 hr prior to use.  The UV254 
source was mounted within an environmental chamber capable of maintaining a constant 
temperature of 4˚C (Percival Scientific, Perry, IA, USA).  The inside of the environmental 
chamber was draped with black burlap to eliminate reflection of the UV254.  To allow lamps 
to reach full operating pressure within the 4˚C environmental chamber, ultraviolet emitting 
lamps were turned on 2 hr prior to commencing the irradiation experiment and 20 minutes 
before each exposure treatment, thereafter.   
 
Virus exposure to ultraviolet          Initial concentrations of 1 x 108.4 (BVDV), 1 x 106.0 
(PRRSV), 1 x 106.0 (influenza virus) and 1 x 109.5 (reovirus)  TCID50 ml-1 were exposed to 
specific UV254 doses (25, 50, 75, 100, 125, 150, 200, 250, and 300 mJ/cm2) by placing 
aliquots (2mm depth) of each virus into 4 separate wells.  One positive control virus (either 
influenza virus Type A, PRRSV, BVDV, or reovirus) was placed in a covered fifth well.  The 
UV254 exposure dose (intensity x time) was determined using the integration function of two 
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commercial radiometers equipped with UV254 sensors (Technika, Scottsdale, AZ, USA).  The 
UV254 doses (n = 9) were replicated 5 times, which corresponded to 45 plates.   
 
To achieve the pre-determined sample exposure dose, the two center wells in one row of each 
plate were removed to accommodate a UV254 sensor.  The viruses were exposed to UV254 by 
the use of an electronically controlled shutter system.  After lamp warm-up (20 min), the 
shutters were opened and the plate exposed to the target dose.  When the dose was reached, 
the UV254 emitter was shut off, the shutter system reset, the next plate placed in the 
environmental chamber, and the UV254 emitters warmed up for 20 minutes prior to exposure.  
Following UV254 exposure, each virus suspension was harvested using a pipette, placed in a 
2ml storage vial labeled with the virus species and a random number, and frozen at -80˚C 
until titrated for infectious virus.  
 
In accordance with the Lamber-Beers Law, the absorbance of any UV254 by the liquid 
medium, UV254 was measured at the top of the 2mm depth of the sample and beneath a quartz 
cuvett containing an equal (2mm) depth of medium.  The measured intensity was corrected 
for absorbance by the viral medium using Equation 2 (Thurston-Enriquez et al. 2003): 
 
(2) ۷average ൌ ۷૙൫૚ି܍
ష܉܍ۺ൯
܉܍ۺ  
Where: 
 Iaverage = average UV254 intensity (milliwatts square centimeter-1) 
 ae  = absorbance of the virus suspension to the base e 
 ۷૙  = UV254 intensity after passing through solution  
 L  = depth (centimeters) of the solution irradiated by the UV254 energy.  
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ANALYSIS 
Two statistical models were used for analysis the UV254 inactivation of each virus. 
 
Model 1.  The one-stage inactivation model (Equation 1) assumed uniform susceptibility of 
the virus population and utilized simple linear regression (Equation 3), with the log-
transformed virus concentration as the response and the dose of UV254 as the explanatory 
variable: 
 
(3) ܔܗ܏૚૙ ۼܜ ൌ ܔܗ܏૚૙ۼ૙ െ ܓ · ۲ܗܛ܍t  
Where: 
 Nt   = quantity of virus in the test sample after treatment with ۲ܗܛ܍t   
 N0  = quantity of virus in the unexposed control sample,  
 k = the inactivation rate  
 Doset  = average UV254 intensity ൈ time 
 
In the one-stage inactivation model, the inactivation constant (k) is the quotient of the 
survival fraction ቀۼܜۼ૙ቁ plotted against the dose.  This linear regression model encompasses all 
of the data points and forces the points into one curve using the classic regression formula, 
ቀെ܊ ൌ  ܕܠܡ ቁ.   
 
Model 2.  The two-stage inactivation model (Equation 4) assumed two heterogeneous 
subpopulations: one relatively susceptible and the other relatively resistant to UV254 
treatment (Nibert and Fields 1992): 
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(4) ܔܗ܏૚૙ ۼܜ ൌ ܔܗ܏૚૙ۼ૙ ൅ ܔܗ܏૚૙ൣሺ૚ െ ࢌሻ · ૚૙ିܓ૚·۲ܗܛ܍ܜ ൅ ࢌ · ૚૙ିܓ૛·۲ܗܛ܍ܜ൧ 
Where: 
 Nt   = quantity of virus in the test sample after treatment with Doset  
 N0  = quantity of virus in the unexposed control sample,  
 f  = the resistant fraction of the total initial virus population with inactivation 
rate k2  
 (1 ‐ f) = the susceptible virus population fraction with inactivation rate k1 
 k1 = the inactivation rate of the inactivation curve for the "fast decay population" 
 k2 = the inactivation rate of the inactivation curve for the "resistant population" 
 Doset = average UV254 intensity ൈ time 
 
The two-stage inactivation model provides two inactivation constants based on the quotient 
of the survival fractions of two separate microbial populations: the UV-susceptible 
population and the resistant population.  The susceptible population (1- f) has an inactivation 
constant of (K1); the resistant population (f) has an inactivation constant of (K2).   
 
The analysis of the data was conducted using SAS® Version 9.2 (SAS® Institute Inc., Cary, 
NC).  Simple linear regression analysis was performed for Model 1 using SAS® procedure 
GLM and non-linear regression analysis was performed for Model 2 using SAS® procedure 
NLIN.  Lack-of-fit F tests were performed to assess whether the two models fit the data 
adequately well, by comparing to a full ANOVA model.  A P-value ≤0.05 was considered 
significant.  
 
RESULTS 
Analysis of the data showed that the one-stage inactivation model did not fit the data (Table 
1).  Specifically, the lack of fit tests for influenza virus (P = 0.0009), PRRSV (P = 0.0002), 
BVDV (P < 0.0001), and reovirus (P = 0.0410) showed a statistically significant difference 
between the observed variation in the data and the variation explained by the single curve 
model for each virus.  Because of the lack of fit, the inactivation constants (k) derived from 
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the one-stage inactivation analysis cannot accurately describe the amount of UV254 needed 
for inactivation of these viruses under the conditions of the study.   
 
Further analysis of the data showed a good fit between the observed variation in data and the 
variation explained by the two-stage inactivation model with lack of fit test P-values > 0.05 
for all viruses (Table 1).  The two-stage model described inactivation curves composed of 
two slopes separated by an inflection point denoting the inactivation kinetics of the two viral 
populations (Figures 1 - 4).  The two-stage inactivation analysis estimated the susceptible 
population (1- f) as 98.8% (influenza virus), 94.1% (PRRSV), 99.9% (BVDV), and 87.3% 
(reovirus) of the total viral population.  Inactivation rates (k1) in the susceptible population 
were calculated as 0.0651 (influenza virus), 0.4995 (PRRSV), 0.0663 (BVDV), and 0.0142 
(reovirus).  The resistant population (f) was a low proportion of the total population of 
influenza virus (1.2%), PRRSV (5.9%), and BVDV (0.07%), but a larger proportion of the 
reovirus population (12.7%).  Compared to the UV254-susceptible population, the resistant 
populations showed lower inactivation constants (k2), i.e., 0.0055 (influenza virus), 0.0143 
(PRRSV), 0.0095 (BVDV), and 0.0035 (reovirus).   
 
DISCUSSION 
Chick's law (Harriet Chick, 1908) describes the rate of microbial inactivation as the ratio of 
the viable population (Nt) to the original microbial population (N0) in relation to exposure 
time (t) to an inactivator (Rubin and Elmaraghy 1977).  The resulting one-stage inactivation 
constant (slope) is an estimate of the rate of microbial inactivation based on the assumption 
of a linear relationship between microbial inactivation and contact time.  This relationship 
has been used to describe the kinetics of microbial populations under a variety of inactivating 
conditions, including exposure to UV254 irradiation (Chang et al. 1985; Kowalski et al. 2001; 
Thurston-Enriquez et al. 2003).  One-stage inactivation estimates are accurate for describing 
UV254 inactivation in homogenous microbial populations (Hiatt 1964).  However, one-stage 
estimates do not address the problem of "tailing off" of UV inactivation curves and may 
over-estimate the rate of inactivation (Hiatt 1964; Hijnen et al. 2006).  Jagger (1967) 
hypothesized that microbial populations were actually composed of two sub-populations; a 
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larger UV254-susceptible population and a smaller UV254-resistant population.  Shortly 
thereafter, Riley and Kaufman (1972) proposed an equation that described the UV254-
inactivation of Serratia marcescens as a two-stage process.   
 
Perhaps because deriving estimates for the two-stage inactivation model were 
computationally demanding prior to availability of desktop computers, the two-stage 
approach has not been widely used to describe the kinetics of microbial inactivation.  For 
example, there are no estimates of UV254 inactivation of BVDV, PRRSV, reovirus strain 
T3DC and influenza virus using the two-stage analysis with which to make comparisons to 
the results reported herein.  Importantly, a comparison of one-stage and two-stage 
inactivation models using experimental data showed that inactivation of the viruses in the 
study was a two-stage process, as confirmed by a statistical lack-of-fit test.  Overall, this 
study supports the validity of the two-stage approach as a method for evaluating UV254 
inactivation kinetics.  In addition, these results provide guidelines to persons responsible for 
the prevention and control of these agents in the environment. 
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TABLES AND FIGURES 
Table 1. Parameter estimates and lack of fit test results for two inactivation models  
 
 
Influenza 
virus * 
PRRSV† BVDV‡ Reovirus§ 
One-Stage Inactivation Model  
Intercept 4.9474 4.4367 7.1911 9.1991 
Inactivation rate (k) -0.0124 -0.0258 -0.0188 -0.0066 
Lack of fit test P-value 0.0009 0.0002 <0.0001 0.0410 
 
Two-Stage Inactivation Modele  
Intercept 5.7970 4.7979 8.4495 9.3996 
Susceptible population proportion (1- f) 0.988 0.941 0.999 0.873 
(K1) Inactivation rate (1- f) -0.0651 -0.4995 -0.0663 -0.0142 
Resistant population proportion (f) 0.012 0.059 0.001 0.127 
(K2) Inactivation rate (f) -0.00552 -0.0143 -0.00948 -0.00347 
Lack of fit test P-value 0.7146 0.0734 0.2227 0.2807 
 
* Influenza A/Swine/Iowa/73 (H1N1) provided by USDA: National Veterinary Service 
Laboratories, Ames, IA  
† PRRSV Type 2 (isolate MN-184) provided by Dr. Scott Dee, University of Minnesota, St. 
Paul, MN 
‡ Bovine viral diarrhea virus type 2 (Singer strain) provided by Dr. J. Ridpath, USDA: 
National Animal Disease Center, Ames, IA 
§ Reovirus strain T3DC provided by Dr. Cathy Miller, Iowa State University, Ames, IA 
e Kowalski et al., 2000 
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Figure 1. Influenza virus:  Linear regression (Lack of fit p = 0.0009,  k = -0.0124) vs.  
two-stage inactivation (Lack of fit p = 0.7146,  k1 = -0.0651,  k2 = -0.0055) 
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Figure 2.  PRRSV:  Linear regression (Lack of fit p = 0.0002,  k = -0.0258) vs. two-stage 
inactivation (Lack of fit p = 0.0734,  k1 = -0.4995,  k2 = -0.0143) 
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Figure 3.  BVDV:  Linear regression (Lack of fit p = <0.0001,  k = -0.0188) vs. two-stage 
inactivation (Lack of fit p = 0.2227,  k1 = -0.0663,  k2 = -0.0095) 
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Figure 4.  Reovirus:  Linear regression (Lack of fit p = 0.0410,  k = -0.0066) vs. two-
stage inactivation (Lack of fit p = 0.2807,  k1 = -0.0142,  k2 = -0.0035) 
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CHAPTER 5.  EFFECT OF TEMPERATURE AND RELATIVE HUMIDITY ON 
ULTRAVIOLET (UV254) INACTIVATION OF AIRBORNE PORCINE 
RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS 
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ABSTRACT 
The objective of this research was to estimate the effects of temperature and relative 
humidity on the inactivation of airborne porcine reproductive and respiratory syndrome 
(PRRS) virus by ultraviolet light (UV254).  Aerosols of PRRS virus were exposed to one of 
four doses of UV254 under nine combinations of temperature (n = 3) and relative humidity (n 
= 3).  Inactivation constants (k), defined as the absolute value of the slope of the linear 
relationship between the survival fraction of the microbial population and the UV254 exposure 
dose, were estimated using the random coefficient model.  The associated UV254 half-life 
dose for each combination of environmental factors was determined as (log102/kሻ and 
expressed as UV254 mJ per unit volume.  The effects of UV254 dose, temperature, and relative 
humidity were all statistically significant, as were the interactions between UV254 
dose*temperature and UV254 dose*relative humidity.  PRRS virus was more susceptible to 
ultraviolet as temperature decreased; most susceptible to ultraviolet inactivation at relative 
humidity between 25 and 79%, less susceptible at relative humidity < 24%, and least 
susceptible at > 80% relative humidity.  The current study allows for calculating the dose of 
UV254 required to inactivate airborne PRRS virus under various laboratory and field 
conditions using the inactivation constants and UV254 half-life doses reported therein. 
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1.0  INTRODUCTION 
Initially described in the late 1980s, porcine reproductive and respiratory syndrome (PRRS) is 
characterized by reproductive failure in sows, poor growth performance in growing pigs, and 
respiratory disease in pigs of all ages (Zimmerman et al., 2006).  Since its emergence as a clinical 
entity in the late 1980’s, PRRS virus has proven to be a persistent threat to the health and 
productivity of pig herds and the economic well-being of pig producers.  Neumann et al. (2005) 
estimated the annual cost of PRRS to U.S. pig producers at $560.32 million per year.  By 
comparison, prior to eradication, annual losses in the U.S. to classical swine fever (hog cholera) 
and pseudorabies virus were estimated at $364.09 million (Wise, 1981) and $36.27 million 
(Hallam et al., 1987), respectively (adjusted to Year 2004 dollars).     
 
Since the beginning of the PRRS virus pandemic in the 1980’s, movement of the virus 
between neighboring herds in the apparent absence of direct contact ("area spread") has been 
reported (Robertson, 1991).  Several epidemiological investigations showed that proximity to 
infected herds increased the risk of a herd acquiring PRRS virus.  Le Potier et al. (1997) found 
that 45% of herds suspected to have become infected through area spread were located within 
500 meters (0.3 miles) of the postulated source herd and only 2% were one kilometer from the 
initial outbreak.  In Denmark it was observed that the likelihood of herd positivity increased as 
the density and proximity of PRRS virus-positive neighboring herds increased (Mortensen et al., 
2002).   
 
In the last decade, researchers have confirmed the occurrence of airborne transmission of 
PRRS virus over significant distances.  Initially, Dee et al. (2005b) demonstrated that 
infectious airborne PRRS virus could travel over distances ≥150 meters.  Thereafter, using a 
source population of 300 PRRS virus-infected pigs, Dee et al. (2009) demonstrated long-
distance airborne movement by the successful recovery of infectious virus up to 4.7 km from 
the source.  Subsequently, Otake et al. (2010) recovered infectious airborne PRRS virus at 
distance of 9.1 km from the source.  Cumulatively, the epidemiological and experimental 
data suggest that airborne PRRS virus is a significant, and perhaps the primary, means of 
area spread. 
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Protection of pig barns from airborne spread of infectious agents is a recent concept. To date, 
researchers have primarily focused on preventing the introduction of airborne PRRS virus 
into barns using commercially-available air filters, e.g., high-efficiency particulate air 
(HEPA) filters, minimum efficiency rating value (MERV) filters of various efficiencies, and 
fiberglass pre-filters.  Overall, the results demonstrated that filtering incoming air with HEPA 
filters and MERV filters ≥ 14 prevented the transmission of PRRS virus (Dee et al., 2005, 
2006a, 2006b, 2010).   
 
Ultraviolet inactivation of PRRS virus may also offer promise.  Wheeler et al. (1945) 
reported the use of ultraviolet to inactivate airborne rubella virus and Streptococcus pyogenes 
in Army and Navy barracks.  Likewise, Perkins et al. (1947) reduced the spread of airborne 
viral pathogens ("measles") in school classrooms using ultraviolet.  Riley (1961) 
demonstrated that ventilated air from hospital tuberculosis wards produced tuberculosis in 
guinea pigs, but not when the air was irradiated with ultraviolet light.  In recent years, UV254 
emitters have been engineered into areas where people congregate either by placing UV254 
light tube grids into existing ventilation ductwork or by installing free standing UVC emitters 
(Brickner et al., 2003; Dumyahn and First, 1999; McDevitt et al., 2007; Menzies et al., 1999; 
Noakes et al, 2006).  Ultraviolet technology is appealing due to its low cost as compared to 
HEPA filtration (Brickner et al., 2003).  However, effective implementation must be based 
on achieving a dose of UV254 sufficient to inactivate the target.  No estimates of the effect of 
UV254 on airborne PRRS virus have been published.  Therefore, the objective of this 
experiment was to evaluate the capability of ultraviolet (UV254) to inactivate airborne PRRS 
virus under varying conditions of temperature and relative humidity. 
 
2.0  MATERIALS AND METHODS 
2.1  Experimental design 
The objective of this study was to evaluate the effect of temperature and relative humidity on 
the inactivation of airborne PRRS virus by ultraviolet irradiation (UV254).  Aerosols of PRRS 
virus were exposed to four levels of UV254 under nine defined conditions of temperature and 
relative humidity (Table 1).  Each combination of temperature and relative humidity was 
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replicated 3 times.  Samples of air collected after UV254 treatment were titrated for infectious 
PRRS virus and the data used to calculate the UV254 inactivation constants (k) and UV254 
half-life (T 1/2) exposure doses for each combination of temperature and relative humidity.   
 
Table 1.   Temperature and relative humidity combinations of PRRS virus aerosols  
  Relative Humidity 
  < 24% 25% to 79% > 80% 
T
em
pe
ra
tu
re
  < 15°C 
Airborne PRRS virus received 4 levels of UV254 treatment 
at each combination of temperature and  relative  
humidity.  Each combination was replicated 3 times.   
16°C to 29°C 
> 30°C 
 
2.2  Porcine reproductive and respiratory syndrome virus 
A type 2 PRRS virus isolate, MN-184 (kindly provided by Dr. Scott Dee, University of 
Minnesota, MN, USA) was propagated on MARC-145 cells, a clone of the African monkey 
kidney cell line MA-104 (Kim et al., 1993).  Cells were grown in 162 cm2 flasks (Corning 
Incorporated, Corning, NY, USA) using growth media; Dulbecco’s Modified Eagles Medium 
(DMEM), (Mediatech Inc., Manassas, VA, USA) supplemented with 0.25 μg/ml 
Amphotericin B (Sigma Chemical Co., St. Louis, MO, USA), 50 μg/ml gentamicin (Sigma), 
0.5 M L-glutamine (Fisher Scientific, Hampton, NH, USA), 300 international units (IU) per 
ml penicillin (Sigma), 300 μg/ml streptomycin (Sigma), 1.0% nonessential amino acids 
(HyClone, Logan, UT, USA), 25 mM HEPES buffer (Sigma Chemical Co.) and 10.0% heat-
inactivated fetal bovine serum (FBS) (Sigma Chemical Co.).  When cells were confluent (72 
to 84 hrs), the medium was discarded and the flasks inoculated with 5 ml DMEM (without L-
glutamine) containing PRRS virus isolate MN-184 at a virus titer of 1 x 103.5 median tissue 
culture infective dose (TCID50) per ml.  Flasks were placed on a rocking platform in a 37°C 
humidified 5% CO2 incubator for 90 min and then 40 ml of supplemented DMEM 
(Mediatech Inc.) growth medium (now with 4% FBS) was added and the flasks returned to 
the incubator for 36 hrs.  Cell culture supernatant was harvested by flask freeze-thaw and 
centrifugation (3000 x g for 20 minutes at 4°C).  Virus stock was stored in 25 ml aliquots at -
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80°C.  
2.3  Experimental procedures 
2.3.1  Overview          The system was constructed such that, throughout the 45 min 
experiment, aerosolized PRRS virus continuously flowed from Reservoir One to Reservoir 
Two and then across a UV254 exposure field.  A manifold in Reservoir Two functioned to 
equally distribute aerosolized PRRS virus into four quartz tubes placed parallel to each other 
in the field of ultraviolet irradiation.  Each quartz tube represented a different level of UV254 
treatment.   
 
Airflow through the system was impelled by negative pressure generated by four AGI-30 
glass impingers (Ace Glass, Vineland, NJ, USA), each operating at a flow rate of 12.5 L per 
min. Thus, air flow through the system totaled 50 L per min.  Temperatures in Reservoir One 
and Reservoir Two were adjusted to achieve targeted temperatures and relative humidities at 
the UV254 irradiation field.  Air samples collected by the impingers downstream of the UV254 
exposure field were titrated for infectious PRRS virus.   
 
2.3.2  Aerosolized PRRS virus          The virus solution to be aerosolized consisted of 25 ml 
of stock PRRS virus (1 × 107 TCID50 per ml), 50 ml of sterile 1X PBS (Thermo Fisher, 
Rockford IL, USA), and 0.1% (v/v) antifoam A emulsion (Sigma Chemical Co., A5758).  
Previous research showed that antifoam A emulsion innocuous for cultured cells and PRRS 
virus (Hermann et al., 2006).  The virus solution was maintained on ice and shielded from 
light until nebulization.  The solution was aerosolized using a 24-jet Collison nebulizer (BGI 
Inc., CN60, Waltham, MA, USA) operating on compressed air at 1.55 kg per cm (22 pounds 
per square inch).  Under these parameters approximately 1.0 ml of virus solution was 
nebulized each minute into particles of approximately 1.9 µm diameter (Hermann et al., 
2007).   
 
2.3.3  Relative humidity and temperature          For each 45 min replicate, virus was 
continuously nebulized into Reservoir One (16 L; aerosol residence time ~19 sec).  Reservoir 
One was housed in a chamber capable of maintaining temperatures between -20°C and room 
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temperature (Carroll Coolers, Inc., Carroll, IA).  Air was drawn from Reservoir One into 
Reservoir Two (13 L; aerosol residence time ~16 sec).  Reservoir Two was housed in a 
chamber capable of maintaining temperatures between 0°C and 40°C (SS Series 600, 1695-
03-36231, Terra Universal, Inc., Anaheim, CA, USA).   
 
Based on the rate of nebulization (1.0 ml per minute at 1.55 kg per cm) and the temperature 
capabilities of Reservoirs One and Two, psychrometric calculations determined that the 
system was theoretically capable of producing an air flow with the RH (%) values listed in 
Table 2, with temperature at the UV254 field of exposure approximating the temperature in 
Reservoir Two.   
 
For each replicate, the actual temperature and relative humidity of the aerosol was measured 
(Vaisala, HMI41 indicator and HMP46 temperature probe, Helsinki, Finland) inside a 
manifold located within Reservoir Two and immediately upstream of the UV254 exposure 
field (Table 1).  Temperature and relative humidity measurements were taken prior to starting 
the replicate and then at the beginning, midpoint and end of each replicate to confirm that the 
system operated at targeted parameters.  All targeted combinations of temperature (n = 3) and 
relative humidity (n = 3) were conducted in triplicate for a total of 9 replicates (Table 1).  
 
Table 2. Calculated relative humidity at the UV254 field of exposure 
 Reservoir One (°C)    
 -20 -15 -10 0 5 10 15 20 25 30    
       
R
el
at
iv
e 
hu
m
id
ity
 (%
) 
20 31 47 100 - - - - - -  0 
R
eservoir Tw
o (°C
) 
14 22 32 70 100 - - - - -  5 
10 16 23 50 71 100 - - - -  10
7 11 17 36 50 72 100 - - -  15
5 8 13 26 37 53 73 100 - -  20
4 6 9 20 28 38 54 74 100 -  25
3 5 7 14 21 30 40 55 75 100  30
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2.3.4  Ultraviolet (UV254) field of exposure          The UV254 emitting apparatus consisted of 
six low-pressure, mercury-vapor discharge lamps 28.8 cm in length (American UV 
Company, Lebanon, IN, USA).  Lamps were mounted in three 2-lamp, reflective, surface-
mounted, 110 volt, fixtures (American UV Company, Lebanon, IN, USA).  To avoid 
fluctuation in UV254 intensity, lamps were operated at their maximum UV254 emission 
capacity for 10 min before the start of each experiment.  UV254 emission was measured using 
three calibrated radiometers (Model 1700, International Light Inc. Newburyport, MA, USA; 
VLX3W Technika, Phoenix, AZ, USA).   
 
Exposure of airborne PRRS virus to UV254 was done by passing the airborne virus through 4 
quartz tubes (10mm internal diameter x 12.75 external diameter x 14cm in length) connected 
to a manifold within Reservoir Two.  Quartz tubes were placed 25 cm from, and parallel to, 
the UV254 emitters.  Between each replicate, quartz tubes were cleaned with commercial 
quartz cleaner following the manufacturer’s recommendations (Hellmanex® II, Hellma 
GmbH & Co., Mülheim, Germany).  Quartz tubing was evaluated for cleanliness and UV254 
absorbance prior to each replicate by measuring UV254 intensity beneath and beside the 
tubing with the impingers in operation (mock aerosol).  No differences in the two 
measurement were detected.  Therefore, UV254 exposure dose measured directly below the 
quartz tubing.  
 
2.3.5  Ultraviolet (UV254) treatment of PRRS virus aerosol          Each of the four quartz 
tubes delivered a different UV254 treatment.  This was achieved by shielding all but a specific 
length of each tube, i.e., 1.3 cm (residence time of 0.07 sec); 3.2 cm (residence time of 0.14 
sec); and 5.2 cm (residence time of 0.25 sec).  A completely shielded tube served as a non-
exposed (positive) control.  Treatment (shielding) was randomized to quartz tubes before 
each replicate.  UV254 irradiance was measured at the unshielded area of each quartz tube at 
the start, midpoint, and end of each replicate and averaged.  For each treatment, the UV254 
dose delivered to airborne PRRS virus was calculated as:   
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 D = I × T       
Where:   
 D  = Ultraviolet dose (mJ per cm2) 
 I  = Irradiance (mW per cm2).  Average of irradiance measured at start, 
midpoint, and end of each replicate. 
 T  = Residence time (sec) 
 
Based on the parameters described above, the mean UV254 exposure doses across all 
replicates for the four treatments were calculated as:  zero for the non-exposed (positive) 
control, 0.05 (S.D. 0.009) mJ per cm2; 0.12 (S.D. 0.016) mJ per cm2, and 0.20 (0.039) mJ per 
cm2.    
 
2.3.6  Sampling of UV254-treated airborne PRRS virus          Each quartz tube was 
independently connected to an all-glass impinger (AGI-30, Ace Glass Inc., Vineland, NJ, 
USA) containing 25 ml of 1X PBS and shielded against ultraviolet.  Impingers were placed 
on ice throughout the 45 minute experiment to avoid dessication of PBS and preserve virus 
viability.  Impingers were operated at a constant flow rate of 12.5 L per min.  Vacuum 
pressure was maintained using oil-less pumps (Fisher Scientific, S413801, Hampton, NH).  
All connections were sealed and checked for leakage prior to each replicate.  Air from the 
system was exhausted through a biosafety level 2 (BL2) cabinet (NuAire Laboratory 
Equipment Supply, Plymouth, MN, USA). 
 
2.3.7  PRRS virus microinfectivity assay (TCID50)          Impinger collection fluid was 
assayed for the concentration of infectious PRRS virus immediately following each replicate.  
Virus titrations were done on confluent monolayers of MARC-145 cells in 96-well plates 
(Corning Incorporated).  Cell monolayers were prepared by inoculating 100 μl of cells 
suspended in growth medium into each well, and then incubating the plates at 37°C in a 
humidified 5% CO2 incubator for 24 hrs.  Each sample was serially 10-fold diluted in 
DMEM, with five wells were inoculated with 100 μl of each sample dilution. Thereafter, 
plates were incubated at 37°C in a humidified 5% CO2 incubator for 2 hrs, after which the 
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inoculum was discarded and 100μl per well of DMEM supplemented with 4% FBS was 
added.  Plates were incubated at 37°C in a humidified 5% CO2 incubator for 24 hrs, after 
which the cells were fixed with aqueous 80% acetone solution and stained with a fluorescein 
isothiocyanate-conjugated monoclonal antibody specific for PRRS virus (SDOW17, Rural 
Technologies, Inc., Brookings, SD, USA).  Virus titers were calculated using the Spearman-
Kärber method on the basis of the number of wells showing PRRS virus-specific 
fluorescence at each dilution and expressed as tissue culture infection dose 50 (TCID50) per 
ml of impinger fluid. 
 
3.0  ANALYSIS 
To analyze the main effects (UV254 dose, temperature, and relative humidity) and their 
interactions, the TCID50 data were log10-transformed and analyzed using a random-
coefficient ANCOVA (analysis of covariance) model with the quantitative explanatory 
variable "UV254 dose" and categorical explanatory variables of "temperature" and "relative 
humidity" in SAS® Version 9.2 (SAS® Institute Inc., Cary, NC, USA).  Inactivation constants 
(k), defined as the absolute value of the slope describing the linear relationship between the 
survival fraction of the microbial population and the UV254 exposure dose (Goldberg et al., 
1958), were estimated using the random coefficient model.  The associated UV254 half-life (T 
1/2) dose for each combination of environmental factors was determined as (log102/kሻ and 
expressed as UV254 mJ per unit volume.  
 
4.0  RESULTS 
The effects of UV254 dose, temperature, and relative humidity on PRRS virus (TCID50) 
recovered in air sample were all statistically significant (p < 0.001), as were the interactions 
between UV254 dose*temperature (p = 0.0475), and UV254 dose*relative humidity (p = 
0.0204).  Inactivation constant estimates and UV254 half-life dose estimates are given in 
Table 3.  Comparisons among the three temperature groups detected a significant difference 
in the UV254 inactivation constant for PRRS virus at low vs. high temperatures (p = 0.0167), 
but not between low vs. medium (p = 0.1044) or medium vs. high temperatures (p = 0.4635).  
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Comparisons among the three levels of relative humidity revealed a statistically significant 
difference in inactivation constants between medium vs. high relative humidity (p = 0.0060), 
but not between and low vs. medium (p = 0.0700) or low vs. high relative humidity (p = 
0.3291).   
 
Table 3.  Inactivation constants and UV254 half-life doses by temperature and relative 
humidity 
 
   Relative Humidity 
   ≤ 24% 25% to 79% ≥ 80% 
  Main effects 4.25 (0.071)* 5.87 (0.051) 3.41 (0.088) 
T
em
pe
ra
tu
re
 ≤ 15°C 5.68 (0.053) 5.42 (0.055) 7.04 (0.043) 4.58 (0.070) 
16°C to 29°C 4.25 (0.071) 3.99 (0.075) 5.61 (0.054) 3.15 (0.096) 
≥ 30°C 3.59 (0.084) 3.33 (0.090) 4.96 (0.061) 2.49 (0.121) 
 
 
 
*Inactivation constant and (half-life).  Inactivation constant (k) is the absolute value of the 
slope of the PRRS virus survival fraction and the UV254 exposure dose.  Larger k values 
indicate more rapid PRRS virus inactivation.  Half-life dose is expressed as uv254 mj per unit 
volume. 
 
5.0  DISCUSSION 
In this study, UV254 inactivation constants for PRRS virus were derived for three temperature 
ranges, three relative humidity ranges, and their combinations.  The effects of temperature 
and relative humidity on the UV254 inactivation of PRRS virus were statistically significant, 
but the interaction of temperature and relative humidity was not.  Ultraviolet inactivation 
constants decreased in a linear fashion as temperature increased, with statistically significant 
differences in inactivation constants detected in low vs. high temperatures, but not between 
low vs. medium or medium vs. high temperatures.  The effect of relative humidity on UV254 
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inactivation was more complex.  For any temperature, the rate of PRRS virus inactivation 
was highest at relative humidity between 25% and 79% and lowest at relative humidity ≥ 
80%.  These observations were reflected in statistically significant differences in inactivation 
constants in medium vs. high relative humidity, but not between other comparisons.   
 
A search of the refereed literature found no publications describing UV254 inactivation of 
airborne viruses under varying conditions of relative humidity and temperature and only two 
publications on UV254 inactivation of airborne viruses under varying conditions of relative 
humidity.  In agreement with the results of this study, Tseng and Li (2005) reported that 
UV254 inactivation of four bacteriophages (MS2, phi X174, phi 6, T7) decreased as relative 
humidity increased at temperatures of 25°C to 28°C and speculated that decreased UV254 
susceptibility under higher relative humidity conditions resulted from attenuation of UV254 by 
water sorption onto the viral surface.  In contrast, in a study involving bacteriophage MS2, 
respiratory adenovirus serotype 2, and mouse hepatitis virus (coronavirus), Walker and Ko 
(2007) reported that UV254 inactivation increased as relative humidity increased (temperature 
conditions not reported).  Walker and Ko (2007) hypothesized that increased UV254 
susceptibility at higher relative humidity could have been a function of larger droplet size at 
higher relative humidities.  Given the overall paucity of data, fruitful hypothesis generation 
regarding the mechanisms underlying the interactions between UV254 inactivation, 
temperature, and relative humidity must await additional data on a the ultraviolet inactivation 
of a greater diversity of micro-organisms.   
 
The current study allows for calculating the dose of UV254 required to inactivate airborne 
PRRS virus under various laboratory and field conditions using the inactivation constants and 
their associated UV254 half-life doses from Table 3.  Since activation constants vary by 
temperature and relative humidity, a conservative estimate of the necessary UV254 dose can 
be made using the smallest inactivation constant (k = 2.49, Table 3) and its associated UV254 
half-life dose.  The percent of the infectious viral population remaining after n UV254 half-life 
doses may be described as (1/2n); thus, the percent of infectious PRRS virus remaining after 
10 UV254 doses may be calculated as (1/210) = 0.1%.  From this, the dose of UV254 required 
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to inactivate 99.9% of airborne PRRS virus may be calculated using figure from Table 3 as 
(0.121 mJ per unit volume/half-life) × (10 half-lifes) = 1.21 mJ per unit volume.  This 
exposure dose may be achieved under different conditions of ultraviolet intensity and 
airflow.  As given by the Bunsen-Roscoe Law of Reciprocity, if achieved, this dose will be 
effective regardless of UV254 intensity or residence time (Riley and Kaufman, 1972).    
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CHAPTER 6.  GENERAL CONCLUSIONS 
Ultraviolet (UV254) inactivation has a long history of use for the disinfection of water and, 
since the publication of Wells and Wells in 1938, for the disinfection of airborne pathogens 
of humans and animals. Overall, the research described in this dissertation has supported the 
historical assessment, i.e., has shown that PRRS virus is susceptible to UV254 inactivation at 
the benchtop.  However, to implement UV254 on at a large scale level will take extensive 
research.  In an agricultural application, the small air volumes and the exposure areas used in 
the experimental setting must be massively scaled up.  To consistently and safely deliver the 
required UV254 dose on the farm will present problems not previously addressed. Other 
significant challenges stand between ultraviolet technology and its routine application for the 
disinfection of air would include the following:   
 
1.  The first challenge is the nomenclature associated with ultraviolet inactivation.  That is, 
there are a variety of interpretations of the terms used in the design and implementation of 
ultraviolet light inactivation; indeed each field has its own terminology and definitions.  For 
example, the word “ultraviolet dose” can mean the amount of energy that a target is exposed 
to (photobiology); the quantum yield, i.e. the number of photons absorbed (photochemistry); 
or fluence measured in watts/cm2 (engineering) (Rahn et al., 2005; Riley, 1994; Thurston-
Enriquez, et al., 2003).  These differences in terminology complicate and obfuscate 
communications across disciplines.  Therefore, more rapid development and routine 
implementation of UV254 necessitates the development of uniform terminology.  
 
2.  The second challenge is the scarcity of estimates on the level of inactivation required to 
prevent transmission.  This question can only be answered by determining the aerosol median 
infectious dose (ID50) for each airborne pathogen.  In fact, the ID50s for most airborne 
pathogens is not known and from the research described in this dissertation we know that 
isolates of the same viral species may have vastly divergent ID50s.  Indeed, VanOsdell and 
Foarde, (2002), state that this missing information is the main factor in preventing the design 
and implementing UV254 disinfection systems on a large scale.   
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3.  From the engineering perspective, the environmental conditions of air temperature, 
relative humidity, air flow rate, and proper emitter type are critical to the efficacy of UV254 
for the control of microorganisms (VanOsdell and Foarde, 2002).  To achieve targeted levels 
of microbial inactivation in a flow through system, emitter type must be paired with 
environmental conditions (VanOsdell and Foarde, 2002).  Furthermore, UV254 inactivation is 
affected by airborne particulate matter that shields microorganisms from UV254.  This is a 
concern as the particulate matter not only shields the microbes but also coats the UV254 
emitters. Therefore, an air filtration system should be employed to remove the particulate 
matter prior to UV254 exposure.  This, by itself forces UV inactivation to be a system that is 
used in tandem with other applications and not as a stand-alone application.  
 
Perhaps in part, the use of ultraviolet for the inactivation of microorganisms is appealing 
because it is a familiar, commercially-available technology and avoids the use of chemicals. 
Recent interest in this approach for the control of bioaerosols has also been stimulated by 
concerns for agro- or bio-terrorism.  However, based on the complexity of this field of 
research and given the current development of the technology, the routine use of ultraviolet 
for the inactivation of microorganisms in aerosols awaits further development.  Because of 
the limitations of the technology described above, ultraviolet may ultimately only function 
effectively in tandem with other technologies, e.g., downstream of filtration systems or in 
photocatalytic systems.   
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